In	O
vivo	O
inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
T-lineage	B-cell_type
cells	I-cell_type
leads	O
to	O
a	O
dramatic	O
decrease	O
in	O
cell	O
proliferation	O
and	O
cytokine	B-protein
production	O
and	O
to	O
increased	O
cell	O
apoptosis	O
in	O
response	O
to	O
mitogenic	O
stimuli	O
,	O
but	O
not	O
to	O
abnormal	O
thymopoiesis	O
.	O

To	O
understand	O
the	O
role	O
of	O
NF-kappa	B-protein
B	I-protein
complexes	O
in	O
T	O
cell	O
development	O
and	O
activation	O
,	O
we	O
have	O
generated	O
transgenic	O
mice	O
in	O
which	O
RelA	B-protein
and	O
c-Rel	B-protein
complexes	I-protein
were	O
selectively	O
inhibited	O
in	O
the	O
T-lineage	B-cell_type
cells	I-cell_type
by	O
specific	O
expression	O
of	O
a	O
trans-dominant	O
form	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

Transgene	O
expression	O
did	O
not	O
affect	O
the	O
thymic	O
development	O
,	O
but	O
led	O
to	O
lowered	O
numbers	O
of	O
splenic	O
T	B-cell_type
cells	I-cell_type
and	O
to	O
a	O
dramatic	O
decrease	O
in	O
the	O
ex	O
vivo	O
proliferative	O
response	O
of	O
splenic	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

Analysis	O
of	O
IL-2	B-protein
and	O
IL-2R	B-protein
alpha	I-protein
expression	O
demonstrated	O
that	O
the	O
perturbation	O
of	O
the	O
proliferation	O
response	O
was	O
not	O
attributable	O
to	O
an	O
abnormal	O
expression	O
of	O
these	O
genes	O
.	O

In	O
contrast	O
,	O
expression	O
of	O
IL-4	B-protein
,	O
IL-10	B-protein
,	O
and	O
IFN-gamma	B-protein
was	O
strongly	O
inhibited	O
in	O
the	O
transgenic	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
proliferative	O
deficiency	O
of	O
the	O
transgenic	B-cell_type
T	I-cell_type
cells	I-cell_type
was	O
associated	O
with	O
an	O
increased	O
apoptosis	O
.	O

These	O
results	O
point	O
out	O
the	O
involvement	O
of	O
NF-kappa	B-protein
B/Rel	I-protein
family	I-protein
proteins	I-protein
in	O
growth	O
signaling	O
pathways	O
by	O
either	O
regulating	B-protein
proteins	I-protein
involved	O
in	O
the	O
IL-2	B-protein
signaling	O
or	O
by	O
functionally	O
interfering	O
with	O
the	O
cell	O
cycle	O
progression	O
.	O

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
.	NULL

:	NULL
CURIOX	NULL
Accelerating	NULL
Life	NULL
Sciences	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
So	NULL
meJournal	NULL
o	NULL
In	NULL
Vivo	NULL
Inhibition	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
in	NULL
T-Lineage	NULL
.	NULL

--	NULL
-f'Immun010	NULL
gy	NULL
Cells	NULL
Leads	NULL
to	NULL
a	NULL
Dramatic	NULL
Decrease	NULL
in	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Cytokine	NULL
Production	NULL
and	NULL
to	NULL
Increased	NULL
Cell	NULL
Apoptosis	NULL
in	NULL
Response	NULL
to	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Mitogenic	NULL
Stimuli	NULL
,	NULL
But	NULL
Not	NULL
to	NULL
Abnormal	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Thymopoiesis	NULL
Valérie	NULL
Ferreira	NULL
,	NULL
Nicolai	NULL
Sidénius	NULL
,	NULL
Nadine	NULL
Tarantino	NULL
,	NULL
Pascale	NULL
Hubert	NULL
,	NULL
Lucienne	NULL
Chatenoud	NULL
,	NULL
Francesco	NULL
Blasi	NULL
and	NULL
Marie	NULL
Korner	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:6442-6450	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/11/6442	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
69	NULL
articles	NULL
,	NULL
37	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/11/6442.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
In	NULL
Vivo	NULL
Inhibition	NULL
of	NULL
NF-rB	NULL
in	NULL
T-Lineage	NULL
Cells	NULL
Leads	NULL
to	NULL
a	NULL
Dramatic	NULL
Decrease	NULL
in	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Cytokine	NULL
Production	NULL
and	NULL
to	NULL
Increased	NULL
Cell	NULL
Apoptosis	NULL
in	NULL
Response	NULL
to	NULL
Mitogenic	NULL
Stimuli	NULL
,	NULL
But	NULL
Not	NULL
to	NULL
Abnormal	NULL
Thymopoiesis	NULL
'	NULL
Valérie	NULL
Ferreira	NULL
,	NULL
*	NULL
Nicolai	NULL
Sidénius	NULL
,	NULL
'	NULL
Nadine	NULL
Tarantino	NULL
,	NULL
*	NULL
Pascale	NULL
Hubert	NULL
,	NULL
*	NULL
Lucienne	NULL
Chatenoud	NULL
,	NULL
*	NULL
Francesco	NULL
Blasi	NULL
,	NULL
'	NULL
and	NULL
Marie	NULL
Kiorner®*	NULL
To	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
complexes	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
activation	NULL
,	NULL
we	NULL
have	NULL
generated	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
RelA	NULL
and	NULL
c-Rel	NULL
complexes	NULL
were	NULL
selectively	NULL
inhibited	NULL
in	NULL
the	NULL
T-lineage	NULL
cells	NULL
by	NULL
specific	NULL
expression	NULL
of	NULL
a	NULL
trans-dominant	NULL
form	NULL
of	NULL
IxBa	NULL
.	NULL

Transgene	NULL
expression	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
thymic	NULL
development	NULL
,	NULL
but	NULL
led	NULL
to	NULL
lowered	NULL
numbers	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
and	NULL
to	NULL
a	NULL
dramatic	NULL
decrease	NULL
in	NULL
the	NULL
ex	NULL
vivo	NULL
proliferative	NULL
response	NULL
of	NULL
splenic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Analysis	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
expression	NULL
demonstrated	NULL
that	NULL
the	NULL
perturbation	NULL
of	NULL
the	NULL
proliferation	NULL
response	NULL
was	NULL
not	NULL
attributable	NULL
to	NULL
an	NULL
abnormal	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IFN-y	NULL
was	NULL
strongly	NULL
inhibited	NULL
in	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
proliferative	NULL
deficiency	NULL
of	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
increased	NULL
apoptosis	NULL
.	NULL

These	NULL
results	NULL
point	NULL
out	NULL
the	NULL
involvement	NULL
of	NULL
NF-B/Rel	NULL
family	NULL
proteins	NULL
in	NULL
growth	NULL
signaling	NULL
pathways	NULL
by	NULL
either	NULL
regulating	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
IL-2	NULL
signaling	NULL
or	NULL
by	NULL
functionally	NULL
interfering	NULL
with	NULL
the	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
6442-6450.	NULL
transcription	NULL
factor	NULL
activated	NULL
in	NULL
T	NULL
lymphocytes	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
triggering	NULL
or	NULL
to	NULL
cytokines	NULL
such	NULL
as	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
numerous	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
and	NULL
inflammation	NULL
(	NULL
4	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-responsive	NULL
genes	NULL
include	NULL
genes	NULL
coding	NULL
for	NULL
various	NULL
regulatory	NULL
cytokines	NULL
,	NULL
adhesion	NULL
molecules	NULL
,	NULL
cell	NULL
surface	NULL
receptors	NULL
,	NULL
and	NULL
immune	NULL
modulators	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
effector	NULL
function	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
thymocytes	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
described	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
vivo	NULL
in	NULL
both	NULL
mice	NULL
and	NULL
humans	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Immunohistochemical	NULL
and	NULL
immunofluorescence	NULL
analyses	NULL
of	NULL
human	NULL
thymocytes	NULL
and	NULL
thymic	NULL
sections	NULL
revealed	NULL
a	NULL
higher	NULL
density	NULL
of	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel/p50	NULL
proteins	NULL
in	NULL
the	NULL
medullary	NULL
thymocytes	NULL
,	NULL
but	NULL
the	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
nuclei	NULL
of	NULL
some	NULL
cortical	NULL
thymocytes	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
mice	NULL
,	NULL
constitutively	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
found	NULL
in	NULL
thymocytes	NULL
from	NULL
both	NULL
embryos	NULL
and	NULL
newborn	NULL
pups	NULL
,	NULL
but	NULL
not	NULL
in	NULL
adult	NULL
thymocytes	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
the	NULL
complex	NULL
maturation	NULL
process	NULL
that	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

The	NULL
prototypical	NULL
NF-KB	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
RelA	NULL
(	NULL
a	NULL
65-kDa	NULL
protein	NULL
)	NULL
and	NULL
p50	NULL
(	NULL
a	NULL
50-kDa	NULL
protein	NULL
,	NULL
processed	NULL
product	NULL
of	NULL
P	NULL
rototypical	NULL
NF-KB	NULL
(	NULL
p50/ReIA	NULL
)	NULL
is	NULL
a	NULL
ubiquitous	NULL
eukaryotic	NULL
*Laboratoire	NULL
d	NULL
'	NULL
Immunologie	NULL
Cellulaire	NULL
et	NULL
Tissulaire	NULL
,	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
UMR	NULL
7627	NULL
,	NULL
Batiment	NULL
Centre	NULL
d'Etudes	NULL
et	NULL
de	NULL
Recherches	NULL
Virologiques	NULL
et	NULL
Immunologiques	NULL
,	NULL
Hopital	NULL
de	NULL
la	NULL
Pitié-Salpétrigre	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
*Unit	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
DIBIT	NULL
,	NULL
Hospital	NULL
San	NULL
Raffaele	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
*Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
Research	NULL
Médicale	NULL
,	NULL
Unit	NULL
25	NULL
,	NULL
Hopital	NULL
Necker	NULL
Enfants	NULL
Malades	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
20	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
17	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
European	NULL
Community	NULL
Grants	NULL
BiotechII	NULL
BIO	NULL
,	NULL
-CT92-0130	NULL
and	NULL
Biomed	NULL
II	NULL
BMH-CT97-2453	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Agence	NULL
Nationale	NULL
de	NULL
Recherche	NULL
sur	NULL
le	NULL
Sida	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
M.	NULL
Kérner	NULL
,	NULL
Laboratoire	NULL
d	NULL
'	NULL
Immunologie	NULL
Cellulaire	NULL
et	NULL
Tissulaire	NULL
,	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
,	NULL
UMR	NULL
7627	NULL
,	NULL
Batiment	NULL
Centre	NULL
d'Etudes	NULL
et	NULL
de	NULL
Recherches	NULL
Virologiques	NULL
et	NULL
Immunologiques	NULL
,	NULL
Hopital	NULL
de	NULL
la	NULL
Pitié-Salpétri¢re	NULL
,	NULL
83	NULL
blvd	NULL
.	NULL

de	NULL
1'HOpital	NULL
,	NULL
75013	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
korner	NULL
@	NULL
cer.jussicu.fr	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
p105	NULL
)	NULL
.	NULL

It	NULL
belongs	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
of	NULL
dimeric	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
also	NULL
includes	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
p52	NULL
(	NULL
processed	NULL
product	NULL
of	NULL
p100	NULL
)	NULL
.	NULL

All	NULL
members	NULL
of	NULL
the	NULL
family	NULL
share	NULL
a	NULL
highly	NULL
conserved	NULL
amino-terminal	NULL
sequence	NULL
called	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
critical	NULL
for	NULL
nuclear	NULL
translocation	NULL
,	NULL
protein-protein	NULL
interactions	NULL
,	NULL
and	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
(	NULL
9	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
complexes	NULL
are	NULL
localized	NULL
typically	NULL
to	NULL
the	NULL
cytoplasm	NULL
,	NULL
where	NULL
they	NULL
bind	NULL
to	NULL
inhibitory	NULL
cytoplasmic	NULL
proteins	NULL
called	NULL
IxBs	NULL
(	NULL
3	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Several	NULL
members	NULL
of	NULL
the	NULL
IB	NULL
regulatory	NULL
family	NULL
have	NULL
been	NULL
characterized	NULL
,	NULL
including	NULL
IxBa	NULL
,	NULL
I	NULL
«	NULL
kBB	NULL
,	NULL
IxBy	NULL
,	NULL
IxBe	NULL
,	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
precursors	NULL
p105	NULL
and	NULL
p100	NULL
,	NULL
and	NULL
Bel3	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
major	NULL
NE-	NULL
«	NULL
B	NULL
dimer	NULL
that	NULL
is	NULL
activated	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
RelA/p50	NULL
,	NULL
but	NULL
c-Rel/p50	NULL
is	NULL
also	NULL
present	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
IxBa-deficient	NULL
mice	NULL
demonstrated	NULL
that	NULL
the	NULL
dominant	NULL
IB	NULL
regulator	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

in	NULL
T	NULL
cells	NULL
is	NULL
IxBa	NULL
(	NULL
12	NULL
)	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
MAD3	NULL
gene	NULL
(	NULL
13	NULL
)	NULL
.	NULL

During	NULL
normal	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
IxBa	NULL
is	NULL
rapidly	NULL
degraded	NULL
via	NULL
the	NULL
ubiquitin-proteasome	NULL
path-way	NULL
,	NULL
permitting	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanism	NULL
resulting	NULL
in	NULL
IxBa	NULL
proteolysis	NULL
is	NULL
complex	NULL
and	NULL
not	NULL
completely	NULL
elucidated	NULL
.	NULL

However	NULL
,	NULL
at	NULL
least	NULL
two	NULL
post-translational	NULL
covalent	NULL
modifications	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
its	NULL
degradation	NULL
.	NULL

The	NULL
first	NULL
post-translational	NULL
event	NULL
resulting	NULL
from	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
phosphorylation	NULL
of	NULL
two	NULL
serines	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
by	NULL
a	NULL
recently	NULL
identified	NULL
group	NULL
of	NULL
IxBa	NULL
kinases	NULL
(	NULL
16-19	NULL
)	NULL
.	NULL

This	NULL
initial	NULL
phosphorylation	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
second	NULL
modification	NULL
of	NULL
IxBa	NULL
,	NULL
which	NULL
is	NULL
the	NULL
ubiquitination	NULL
of	NULL
lysines	NULL
21	NULL
and	NULL
22	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
ubiquitination	NULL
of	NULL
IxBa	NULL
results	NULL
in	NULL
its	NULL
rapid	NULL
degradation	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Substitution	NULL
of	NULL
the	NULL
two	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
by	NULL
alanine	NULL
residues	NULL
protects	NULL
IxBa	NULL
from	NULL
ubiquitination	NULL
and	NULL
protea-some-mediated	NULL
proteolysis	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
if	NULL
expressed	NULL
in	NULL
sufficient	NULL
amounts	NULL
,	NULL
the	NULL
double-mutated	NULL
IxBa	NULL
prevents	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
transiently	NULL
or	NULL
stably	NULL
transfected	NULL
cells	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

Despite	NULL
accumulating	NULL
amounts	NULL
of	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
data	NULL
suggesting	NULL
an	NULL
important	NULL
role	NULL
for	NULL
NF-	NULL
«	NULL
B/Rel	NULL
in	NULL
immunity	NULL
and	NULL
inflam-mation	NULL
,	NULL
the	NULL
full	NULL
role	NULL
of	NULL
this	NULL
family	NULL
of	NULL
proteins	NULL
in	NULL
vivo	NULL
remained	NULL
unclear	NULL
.	NULL

To	NULL
better	NULL
understand	NULL
the	NULL
function	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
a	NULL
series	NULL
of	NULL
gene	NULL
knockout	NULL
experiments	NULL
was	NULL
performed	NULL
.	NULL

Mice	NULL
lacking	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
p50	NULL
or	NULL
c-Rel	NULL
exhibited	NULL
deficiencies	NULL
of	NULL
mature	NULL
lymphocyte	NULL
proliferation	NULL
as	NULL
well	NULL
as	NULL
increased	NULL
susceptibility	NULL
to	NULL
certain	NULL
pathogens	NULL
,	NULL
but	NULL
T	NULL
cell	NULL
development	NULL
remained	NULL
normal	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Preliminary	NULL
reports	NULL
suggested	NULL
that	NULL
mice	NULL
lacking	NULL
p52	NULL
have	NULL
a	NULL
similar	NULL
phenotype	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Mice	NULL
lacking	NULL
RelB	NULL
develop	NULL
diffuse	NULL
T	NULL
lymphocyte-dependent	NULL
inflammatory	NULL
infiltrates	NULL
and	NULL
granulocytosis	NULL
,	NULL
and	NULL
present	NULL
a	NULL
defect	NULL
of	NULL
dendritic	NULL
cell	NULL
development	NULL
in	NULL
lymphoid	NULL
organs	NULL
rather	NULL
than	NULL
an	NULL
intrinsic	NULL
defect	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Mice	NULL
lacking	NULL
RelA	NULL
do	NULL
not	NULL
survive	NULL
past	NULL
the	NULL
15th	NULL
day	NULL
of	NULL
gestation	NULL
because	NULL
of	NULL
apoptosis	NULL
of	NULL
developing	NULL
hepatocytes	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
this	NULL
,	NULL
the	NULL
development	NULL
and	NULL
functionality	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RelA	NULL
could	NULL
not	NULL
be	NULL
examined	NULL
directly	NULL
.	NULL

However	NULL
,	NULL
transplantation	NULL
of	NULL
RelA	NULL
knockout	NULL
embryonic	NULL
stem	NULL
cells	NULL
into	NULL
SCID	NULL
mice	NULL
resulted	NULL
in	NULL
normal	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
development	NULL
,	NULL
suggesting	NULL
that	NULL
RelA	NULL
is	NULL
dispensable	NULL
for	NULL
differentiation	NULL
and	NULL
maturation	NULL
of	NULL
lymphocytes	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
potential	NULL
functional	NULL
redundancy	NULL
among	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
members	NULL
has	NULL
to	NULL
be	NULL
considered	NULL
,	NULL
and	NULL
this	NULL
complicates	NULL
the	NULL
understanding	NULL
of	NULL
these	NULL
gene	NULL
disruption	NULL
experiments	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

To	NULL
circumvent	NULL
the	NULL
problem	NULL
of	NULL
functional	NULL
redundancy	NULL
of	NULL
NF-KB	NULL
members	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
and	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
T	NULL
cell-depen-dent	NULL
immune	NULL
response	NULL
,	NULL
we	NULL
(	NULL
the	NULL
present	NULL
paper	NULL
)	NULL
and	NULL
others	NULL
(	NULL
31	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
have	NULL
generated	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
RelA-	NULL
and	NULL
c-Rel-NF-	NULL
«	NULL
B	NULL
were	NULL
selectively	NULL
inhibited	NULL
in	NULL
the	NULL
T-lineage	NULL
cells	NULL
.	NULL

This	NULL
was	NULL
achieved	NULL
by	NULL
using	NULL
a	NULL
transgene	NULL
representing	NULL
a	NULL
frans-dominant	NULL
form	NULL
of	NULL
IxBa	NULL
.	NULL

While	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

used	NULL
an	NULL
N-terminal-deleted	NULL
IxBa	NULL
transgene	NULL
,	NULL
IxB	NULL
(	NULL
AN	NULL
)	NULL
,	NULL
we	NULL
used	NULL
a	NULL
mutated	NULL
IxBa	NULL
,	NULL
termed	NULL
IxBa	NULL
(	NULL
32/	NULL
36A	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
two	NULL
serines	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
were	NULL
substituted	NULL
by	NULL
alanines	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
was	NULL
under	NULL
lineage-specific	NULL
control	NULL
of	NULL
the	NULL
proximal	NULL
Ick	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
.	NULL

This	NULL
mutated	NULL
IxBa	NULL
inhibitor	NULL
repressed	NULL
constitutively	NULL
the	NULL
nuclear	NULL
import	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
RelA-	NULL
and	NULL
c-Rel-NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
stably	NULL
transfected	NULL
human	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
in	NULL
transitory	NULL
transfection	NULL
experiments	NULL
.	NULL

In	NULL
mice	NULL
,	NULL
our	NULL
results	NULL
demonstrated	NULL
that	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
constituted	NULL
a	NULL
powerful	NULL
NF-	NULL
«	NULL
B	NULL
inhibitor	NULL
in	NULL
thymocytes	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
by	NULL
inhibiting	NULL
both	NULL
RelA-	NULL
and	NULL
c-ReI-NF-	NULL
«	NULL
B	NULL
activities	NULL
.	NULL

Several	NULL
biological	NULL
consequences	NULL
of	NULL
the	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
transgene	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
such	NULL
as	NULL
1	NULL
)	NULL
a	NULL
decreased	NULL
number	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
,	NULL
especially	NULL
the	NULL
CD8	NULL
*	NULL
subpopulation	NULL
;	NULL
2	NULL
)	NULL
a	NULL
dramatic	NULL
decrease	NULL
in	NULL
the	NULL
ex	NULL
vivo	NULL
proliferative	NULL
response	NULL
of	NULL
T	NULL
lymphocytes	NULL
;	NULL
and	NULL
3	NULL
)	NULL
increased	NULL
apoptosis	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
show	NULL
in	NULL
this	NULL
report	NULL
the	NULL
effect	NULL
of	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
on	NULL
ex	NULL
vivo	NULL
production	NULL
of	NULL
a	NULL
series	NULL
of	NULL
cytokines	NULL
.	NULL

While	NULL
IL-4	NULL
and	NULL
IL-10	NULL
cytokines	NULL
were	NULL
transcriptionally	NULL
inhibited	NULL
,	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
remained	NULL
normal	NULL
in	NULL
IkBa	NULL
(	NULL
32/	NULL
36A	NULL
)	NULL
mice	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Generation	NULL
of	NULL
transgenic	NULL
mice	NULL
expressing	NULL
IxBa	NULL
(	NULL
32/364	NULL
)	NULL
Generation	NULL
of	NULL
human	NULL
IxBa	NULL
cDNA	NULL
,	NULL
substituted	NULL
by	NULL
alanines	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
(	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
)	NULL
,	NULL
was	NULL
described	NULL
by	NULL
Traenckner	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
and	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
P.	NULL
Bacuerle	NULL
(	NULL
Tularik	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
p1017-Ick	NULL
plasmid	NULL
containing	NULL
the	NULL
murine	NULL
Ick	NULL
proximal	NULL
promoter	NULL
and	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
hGH	NULL
)	NULL
minigene	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
termination	NULL
codon	NULL
from	NULL
the	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
32/36A	NULL
)	NULL
cDNA	NULL
resulted	NULL
in	NULL
a	NULL
3	NULL
'	NULL
end	NULL
tag	NULL
corresponding	NULL
to	NULL
30	NULL
aa	NULL
at	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
resulting	NULL
transgenic	NULL
protein	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
the	NULL
tagged	NULL
transgene	NULL
(	NULL
TnT	NULL
T7	NULL
quick	NULL
coupled	NULL
transcription/translation	NULL
system	NULL
,	NULL
Promega	NULL
)	NULL
produced	NULL
proteins	NULL
presenting	NULL
apparent	NULL
m.w	NULL
.	NULL

of	NULL
58,000	NULL
and	NULL
45,000	NULL
in	NULL
SDS-PAGE	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
6.2-kb	NULL
NofI	NULL
fragment	NULL
containing	NULL
the	NULL
Ick	NULL
promoter	NULL
,	NULL
the	NULL
tagged	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
cDNA	NULL
,	NULL
and	NULL
hGH	NULL
minigene	NULL
from	NULL
the	NULL
plasmide	NULL
p1017-IxBa	NULL
(	NULL
32/36	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
gel	NULL
purification	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
the	NULL
purified	NULL
linear	NULL
DNA	NULL
was	NULL
adjusted	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
hGH	NULL
,	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
Luc	NULL
,	NULL
luciferase	NULL
;	NULL
CDK	NULL
,	NULL
cyclin-dependent	NULL
kinase	NULL
.	NULL

6443	NULL
to	NULL
3	NULL
ug/ml	NULL
in	NULL
injection	NULL
buffer	NULL
(	NULL
0.25	NULL
mM	NULL
EDTA	NULL
and	NULL
5	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
before	NULL
microinjection	NULL
.	NULL

All	NULL
techniques	NULL
used	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
transgenic	NULL
mice	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
transgenic	NULL
mice	NULL
were	NULL
generated	NULL
by	NULL
pronuclear	NULL
microinjection	NULL
of	NULL
0.5	NULL
days	NULL
postcoitus	NULL
embryos	NULL
obtained	NULL
from	NULL
6-wk-old	NULL
superovulated	NULL
C57B16XCBAF1	NULL
females	NULL
mated	NULL
with	NULL
males	NULL
of	NULL
the	NULL
same	NULL
genotype	NULL
.	NULL

Injected	NULL
eggs	NULL
were	NULL
implanted	NULL
into	NULL
pseudopregnant	NULL
CD1	NULL
females	NULL
.	NULL

Three	NULL
transgenic	NULL
founder	NULL
animals	NULL
(	NULL
5	NULL
,	NULL
3	NULL
,	NULL
and	NULL
23	NULL
)	NULL
were	NULL
identified	NULL
by	NULL
PCR	NULL
and	NULL
confirmed	NULL
by	NULL
Southern	NULL
blotting	NULL
on	NULL
genomic	NULL
DNA	NULL
obtained	NULL
from	NULL
small	NULL
tail	NULL
biopsies	NULL
.	NULL

All	NULL
animals	NULL
were	NULL
obtained	NULL
from	NULL
Charles	NULL
River	NULL
Italy	NULL
(	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
and	NULL
were	NULL
kept	NULL
under	NULL
specific	NULL
pathogen-free	NULL
conditions	NULL
.	NULL

The	NULL
restriction	NULL
of	NULL
IxBa	NULL
(	NULL
32/	NULL
36A	NULL
)	NULL
transgene	NULL
expression	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
protein	NULL
extracts	NULL
from	NULL
spleen	NULL
,	NULL
liver	NULL
,	NULL
brain	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
purified	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

T	NULL
cell	NULL
preparation	NULL
Cells	NULL
from	NULL
thymus	NULL
and	NULL
spleen	NULL
were	NULL
prepared	NULL
by	NULL
crushing	NULL
the	NULL
organs	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
standard	NULL
concentrations	NULL
of	NULL
glutamine	NULL
and	NULL
antibiotics	NULL
)	NULL
.	NULL

After	NULL
hypotonic	NULL
lysis	NULL
of	NULL
erythrocytes	NULL
,	NULL
the	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
depleted	NULL
of	NULL
B	NULL
cells	NULL
by	NULL
chromatography	NULL
through	NULL
nylon	NULL
wool	NULL
columns	NULL
(	NULL
39	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
adsorption	NULL
on	NULL
pan-B	NULL
Abs	NULL
coupled	NULL
to	NULL
magnetic	NULL
beads	NULL
(	NULL
B220	NULL
,	NULL
Dynal	NULL
,	NULL
Compiégne	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
population	NULL
was	NULL
systematically	NULL
95	NULL
%	NULL
T	NULL
cells	NULL
and	NULL
1	NULL
%	NULL
B	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Western	NULL
blotting	NULL
and	NULL
immunoprecipitation	NULL
Cytoplasmic	NULL
extracts	NULL
from	NULL
thymocytes	NULL
and	NULL
splenocytes	NULL
were	NULL
prepared	NULL
by	NULL
hypotonic	NULL
disruption	NULL
of	NULL
cells	NULL
(	NULL
5	NULL
mM	NULL
HEPES	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
0.1	NULL
mM	NULL
aprotinin	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
on	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
IxBa	NULL
proteins	NULL
were	NULL
visualized	NULL
using	NULL
an	NULL
mAb	NULL
(	NULL
MAD1IOB	NULL
)	NULL
specific	NULL
for	NULL
an	NULL
N-terminal	NULL
domain	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
40	NULL
)	NULL
,	NULL
the	NULL
HRP-coupled	NULL
anti-mouse	NULL
Ab	NULL
,	NULL
and	NULL
the	NULL
Amersham	NULL
enhanced	NULL
chemiluminescence	NULL
visualization	NULL
system	NULL
kit	NULL
(	NULL
Arling-ton	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

EMSAs	NULL
Nuclear	NULL
proteins	NULL
from	NULL
either	NULL
resting	NULL
or	NULL
1-h	NULL
PMA-	NULL
plus	NULL
ionomycin-treated	NULL
thymocytes	NULL
or	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
reaction	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
41	NULL
)	NULL
using	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
and	NULL
°°P	NULL
5	NULL
'	NULL
end-labeled	NULL
oligonucleotide	NULL
coding	NULL
for	NULL
the	NULL
tandem	NULL
B	NULL
sequence	NULL
from	NULL
the	NULL
HIV-long	NULL
terminal	NULL
repeat	NULL
enhancer	NULL
.	NULL

The	NULL
resulting	NULL
protein-oligonucleotide	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
6	NULL
%	NULL
PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Cell	NULL
proliferation	NULL
assays	NULL
Purified	NULL
splenic	NULL
T	NULL
cells	NULL
(	NULL
250,000	NULL
cells/well	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
plates	NULL
in	NULL
triplicate	NULL
with	NULL
250	NULL
ng/ml	NULL
ionomycin	NULL
plus	NULL
10	NULL
ng/ml	NULL
PMA	NULL
or	NULL
with	NULL
coated	NULL
anti-CD3e	NULL
145	NULL
2C11	NULL
Ab	NULL
(	NULL
0.5	NULL
ug/well	NULL
)	NULL
(	NULL
42	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
PV-I	NULL
(	NULL
6Ga	NULL
)	NULL
Ab	NULL
(	NULL
0.5	NULL
pug/well	NULL
;	NULL
provided	NULL
by	NULL
Dr.	NULL
Carl	NULL
June	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
48	NULL
or	NULL
72	NULL
h.	NULL
Tritiated	NULL
thymidine	NULL
,	NULL
(	NULL
1	NULL
wCi	NULL
)	NULL
from	NULL
ICN	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
for	NULL
an	NULL
additional	NULL
12	NULL
h.	NULL
Cultured	NULL
cells	NULL
were	NULL
then	NULL
harvested	NULL
(	NULL
Scatron	NULL
,	NULL
Tranby	NULL
,	NULL
Nor-way	NULL
)	NULL
,	NULL
and	NULL
incorporated	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
was	NULL
analyzed	NULL
by	NULL
scintillation	NULL
count-ing	NULL
.	NULL

Quantitation	NULL
of	NULL
cytokine	NULL
mRNA	NULL
by	NULL
RT-PCR	NULL
RNAs	NULL
were	NULL
prepared	NULL
from	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
by	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
or	NULL
by	NULL
coated	NULL
145	NULL
2C11	NULL
anti-CD3e	NULL
Ab	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate	NULL
method	NULL
with	NULL
minor	NULL
modifications	NULL
(	NULL
43	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
examined	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IFN-y	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
B-actin	NULL
transcripts	NULL
by	NULL
a	NULL
semiquantitative	NULL
reverse	NULL
transcribed	NULL
PCR	NULL
.	NULL

Commercial	NULL
primer	NULL
sets	NULL
were	NULL
provided	NULL
by	NULL
Stratagene	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
by	NULL
ELISA	NULL
and	NULL
CTLL-2	NULL
proliferation	NULL
Production	NULL
of	NULL
IL-2	NULL
by	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
mitogens	NULL
was	NULL
estimated	NULL
using	NULL
an	NULL
IL-2-dependent	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
CTLL-2	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Purified	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
mitogens	NULL
(	NULL
10	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
250	NULL
ng/ml	NULL
ionomycin	NULL
or	NULL
coated	NULL
145	NULL
2C11	NULL
anti-CD3	NULL
Ab	NULL
alone	NULL
(	NULL
5	NULL
ug	NULL
in	NULL
500	NULL
1	NULL
)	NULL
or	NULL
in	NULL
association	NULL
with	NULL
CD28-specific	NULL
PV-1	NULL
(	NULL
6Ga	NULL
)	NULL
Ab	NULL
(	NULL
5	NULL
ug	NULL
in	NULL
500	NULL
gl	NULL
)	NULL
)	NULL
for	NULL
24-48	NULL
h.	NULL
Supernatants	NULL
from	NULL
the	NULL
T	NULL
cells	NULL
(	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
harvested	NULL
and	NULL
tested	NULL
for	NULL
IL-2	NULL
by	NULL
CTLL-2	NULL
proliferation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Production	NULL
of	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
using	NULL
plates	NULL
precoated	NULL
with	NULL
anti-mouse	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
Abs	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6444	NULL
T	NULL
CELL	NULL
ACTIVATION	NULL
AND	NULL
DEVELOPMENT	NULL
IN	NULL
IxBa	NULL
TRANSGENIC	NULL
MICE	NULL
and	NULL
IFN-y	NULL
were	NULL
quantified	NULL
by	NULL
comparison	NULL
to	NULL
standard	NULL
proteins	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

All	NULL
tests	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Production	NULL
of	NULL
IL-4	NULL
by	NULL
ELA	NULL
cell	NULL
clones	NULL
was	NULL
also	NULL
monitored	NULL
by	NULL
ELISA	NULL
.	NULL

Stable	NULL
transfections	NULL
of	NULL
EL4	NULL
cells	NULL
The	NULL
parental	NULL
Th2	NULL
murine	NULL
cell	NULL
line	NULL
,	NULL
EL4	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collec-tion	NULL
)	NULL
,	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
glutamine	NULL
,	NULL
antibiot-ics	NULL
,	NULL
2-ME	NULL
,	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Expression	NULL
vector	NULL
pCMV-I	NULL
«	NULL
Ba	NULL
(	NULL
32/36A	NULL
)	NULL
was	NULL
made	NULL
by	NULL
inserting	NULL
MAD3	NULL
cDNA	NULL
mutant	NULL
(	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
)	NULL
into	NULL
the	NULL
XbaUV/HindIII	NULL
sites	NULL
of	NULL
the	NULL
pcDNA3	NULL
vector	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Expression	NULL
vector	NULL
pCMV-IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
tag	NULL
was	NULL
made	NULL
by	NULL
inserting	NULL
the	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
-tagged	NULL
murine	NULL
transgene	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
the	NULL
peDNA3	NULL
vector	NULL
.	NULL

EL4	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pCMV-IxBa	NULL
(	NULL
32/36	NULL
)	NULL
,	NULL
pCMV-IxBa	NULL
(	NULL
32/36	NULL
)	NULL
tag	NULL
,	NULL
or	NULL
the	NULL
empty	NULL
pcDNA3	NULL
vector	NULL
by	NULL
electropora-tion	NULL
.	NULL

G418-resistant	NULL
cells	NULL
were	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
and	NULL
were	NULL
geno-typed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
the	NULL
mAb	NULL
MAD	NULL
10B	NULL
or	NULL
by	NULL
PCR	NULL
using	NULL
MAD3-and	NULL
hGH-specific	NULL
primers	NULL
.	NULL

The	NULL
clones	NULL
with	NULL
stable	NULL
integration	NULL
of	NULL
the	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
transgene	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
mg/ml	NULL
G418	NULL
.	NULL

Luciferase	NULL
(	NULL
Luc	NULL
)	NULL
assays	NULL
The	NULL
following	NULL
vectors	NULL
were	NULL
used	NULL
for	NULL
«	NULL
B-dependent	NULL
Luc	NULL
assays	NULL
.	NULL

The	NULL
4p110-Luc	NULL
and	NULL
4p575-Luc	NULL
constructs	NULL
(	NULL
45	NULL
)	NULL
,	NULL
which	NULL
contain	NULL
110	NULL
and	NULL
575	NULL
bp	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
promoter	NULL
,	NULL
were	NULL
provided	NULL
by	NULL
Prof.	NULL
W.	NULL
Paul	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
the	NULL
EL4	NULL
cell	NULL
clones	NULL
with	NULL
Luc	NULL
vectors	NULL
were	NULL
performed	NULL
by	NULL
electroporation	NULL
(	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
,	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA/S	NULL
X	NULL
10°	NULL
cells	NULL
.	NULL

Two	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
two	NULL
pools	NULL
.	NULL

One	NULL
pool	NULL
of	NULL
cells	NULL
was	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
,	NULL
and	NULL
the	NULL
other	NULL
pool	NULL
was	NULL
incubated	NULL
with	NULL
10	NULL
ng/ml	NULL
PMA	NULL
plus	NULL
250	NULL
ng/ml	NULL
ionomycin	NULL
for	NULL
24	NULL
h.	NULL
Luc	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Promega	NULL
luciferase	NULL
assay	NULL
system	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Light	NULL
emission	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
calculated	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
light	NULL
emission/background/milligrams	NULL
of	NULL
protein	NULL
)	NULL
.	NULL

Transfections	NULL
experiments	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

Results	NULL
Expression	NULL
and	NULL
functionality	NULL
of	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
transgene	NULL
We	NULL
have	NULL
generated	NULL
transgenic	NULL
mice	NULL
that	NULL
integrated	NULL
a	NULL
tagged	NULL
mutated	NULL
form	NULL
of	NULL
IxBa	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
lineage-specific	NULL
Ick	NULL
proximal	NULL
promoter	NULL
and	NULL
the	NULL
hGH	NULL
minigene	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

To	NULL
check	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
experiments	NULL
using	NULL
cytosolic	NULL
protein	NULL
extracts	NULL
from	NULL
thymocytes	NULL
of	NULL
three	NULL
founder	NULL
mice	NULL
lines	NULL
,	NULL
Tg	NULL
3	NULL
,	NULL
Tg	NULL
23	NULL
,	NULL
and	NULL
Tg	NULL
5	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
expressed	NULL
transgenic	NULL
IxBa	NULL
in	NULL
these	NULL
animals	NULL
correlated	NULL
with	NULL
integration	NULL
copy	NULL
number	NULL
as	NULL
determined	NULL
by	NULL
Southern	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
mice	NULL
from	NULL
the	NULL
Tg	NULL
5	NULL
line	NULL
expressed	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
the	NULL
transgenic	NULL
IxBa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
Tg	NULL
3	NULL
mice	NULL
produced	NULL
the	NULL
lowest	NULL
amount	NULL
of	NULL
the	NULL
transgene	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
major	NULL
form	NULL
of	NULL
the	NULL
transgene	NULL
migrated	NULL
as	NULL
a	NULL
58-kDa	NULL
protein	NULL
.	NULL

The	NULL
minor	NULL
form	NULL
of	NULL
the	NULL
transgene	NULL
appeared	NULL
as	NULL
a	NULL
45-kDa	NULL
protein	NULL
and	NULL
was	NULL
detectable	NULL
mostly	NULL
in	NULL
the	NULL
Tg	NULL
5	NULL
line	NULL
.	NULL

Both	NULL
the	NULL
58-	NULL
and	NULL
45-kDa	NULL
forms	NULL
were	NULL
obtained	NULL
by	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
assay	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
do	NULL
not	NULL
result	NULL
from	NULL
a	NULL
recombination	NULL
or	NULL
splicing	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
vivo	NULL
.	NULL

Specific	NULL
Abs	NULL
raised	NULL
against	NULL
the	NULL
30-aa	NULL
tag	NULL
also	NULL
recognized	NULL
both	NULL
58-	NULL
and	NULL
45-kDa	NULL
forms	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
immunoprecipitation	NULL
of	NULL
thymocyte	NULL
protein	NULL
extracts	NULL
with	NULL
an	NULL
Ab	NULL
specific	NULL
for	NULL
the	NULL
carboxyl-terminal	NULL
portion	NULL
of	NULL
the	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
an	NULL
mAb	NULL
specific	NULL
for	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
IxBa	NULL
revealed	NULL
that	NULL
both	NULL
58-	NULL
and	NULL
45-kDa	NULL
forms	NULL
are	NULL
composed	NULL
of	NULL
IxBa	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
tagged	NULL
mutated	NULL
IxBa	NULL
cDNA	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
protein	NULL
presenting	NULL
two	NULL
conformations	NULL
.	NULL

The	NULL
preferential	NULL
conformation	NULL
in	NULL
denaturing	NULL
conditions	NULL
had	NULL
a	NULL
m.w	NULL
.	NULL

of	NULL
58,000	NULL
,	NULL
but	NULL
a	NULL
minor	NULL
form	NULL
of	NULL
45,000	NULL
was	NULL
also	NULL
detected	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
IxBa	NULL
gene	NULL
regulation	NULL
studies	NULL
(	NULL
24	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
in	NULL
the	NULL
most	NULL
highly	NULL
expressing	NULL
transgenic	NULL
thymocytes	NULL
(	NULL
Tg	NULL
5	NULL
)	NULL
the	NULL
level	NULL
of	NULL
the	NULL
endogenous	NULL
form	NULL
of	NULL
IxBa	NULL
was	NULL
reduced	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
control	NULL
mice	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
Ick	NULL
promoter	NULL
was	NULL
initially	NULL
described	NULL
as	NULL
being	NULL
mostly	NULL
active	NULL
in	NULL
thymocytes	NULL
,	NULL
we	NULL
sought	NULL
expression	NULL
of	NULL
the	NULL
transgenic	NULL
IxBa	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
purified	NULL
from	NULL
spleens	NULL
.	NULL

Western	NULL
blotting	NULL
of	NULL
the	NULL
cytosolic	NULL
extracts	NULL
from	NULL
purified	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
splenic	NULL
populations	NULL
clearly	NULL
indicated	NULL
that	NULL
the	NULL
transgene	NULL
was	NULL
also	NULL
produced	NULL
in	NULL
splenic	NULL
cells	NULL
,	NULL
but	NULL
exclusively	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
in	NULL
vivo	NULL
transgenesis	NULL
studies	NULL
using	NULL
Ick	NULL
proximal	NULL
promoter	NULL
(	NULL
37	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
transgene	NULL
is	NULL
less	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
than	NULL
in	NULL
thymocytes	NULL
.	NULL

This	NULL
decrease	NULL
in	NULL
(	NULL
32/36	NULL
)	NULL
protein	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
correlated	NULL
with	NULL
an	NULL
increment	NULL
in	NULL
endogenous	NULL
IxBa	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
comparison	NULL
between	NULL
purified	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
revealed	NULL
that	NULL
both	NULL
populations	NULL
expressed	NULL
comparable	NULL
levels	NULL
of	NULL
the	NULL
transgenic	NULL
IxBa	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
functionality	NULL
of	NULL
the	NULL
transgene	NULL
,	NULL
we	NULL
estimated	NULL
the	NULL
nuclear	NULL
translocation	NULL
capacity	NULL
of	NULL
the	NULL
RelA-	NULL
and	NULL
c-Rel-NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
activation	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
1-h	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
of	NULL
isolated	NULL
thymocytes	NULL
from	NULL
control	NULL
and	NULL
transgenic	NULL
mice	NULL
revealed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
inhibited	NULL
in	NULL
the	NULL
three	NULL
transgenic	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
was	NULL
dose	NULL
dependent	NULL
on	NULL
the	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
expression	NULL
,	NULL
since	NULL
in	NULL
the	NULL
low	NULL
transgene	NULL
producer	NULL
(	NULL
Tg	NULL
3	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
only	NULL
reduced	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
two	NULL
other	NULL
lines	NULL
(	NULL
5	NULL
and	NULL
23	NULL
)	NULL
,	NULL
which	NULL
produce	NULL
higher	NULL
amounts	NULL
of	NULL
the	NULL
transgene	NULL
,	NULL
no	NULL
mitogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
detected	NULL
.	NULL

In	NULL
splenic	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
was	NULL
less	NULL
potent	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
corresponding	NULL
thymocytes	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
correlated	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
IxBa	NULL
transgene	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
and	NULL
indicated	NULL
that	NULL
in	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
transgenic	NULL
IxkBa	NULL
was	NULL
not	NULL
sufficient	NULL
for	NULL
complete	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
.	NULL

Supershift	NULL
experiments	NULL
identified	NULL
the	NULL
residual	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
as	NULL
being	NULL
RelA-p50	NULL
dimer	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
approach	NULL
did	NULL
not	NULL
find	NULL
c-Rel	NULL
in	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
and	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
mice	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
small	NULL
amounts	NULL
of	NULL
c-Rel	NULL
activity	NULL
remain	NULL
in	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
activity	NULL
was	NULL
due	NULL
to	NULL
a	NULL
direct	NULL
interaction	NULL
of	NULL
the	NULL
58-kDa	NULL
transgene	NULL
with	NULL
NF-KB	NULL
proteins	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
immunoprecipitation	NULL
assays	NULL
of	NULL
proteins	NULL
extracted	NULL
from	NULL
transgenic	NULL
thymocytes	NULL
with	NULL
RelA-	NULL
and	NULL
c-Rel-specific	NULL
Abs	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
demonstrated	NULL
that	NULL
the	NULL
transgenic	NULL
IkBa	NULL
,	NULL
in	NULL
its	NULL
major	NULL
58-kDa	NULL
conformation	NULL
,	NULL
efficiently	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
thymocytes	NULL
by	NULL
interacting	NULL
with	NULL
both	NULL
RelA	NULL
and	NULL
c-Rel	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
and	NULL
induced	NULL
a	NULL
partial	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

Biological	NULL
effects	NULL
of	NULL
the	NULL
IxBa	NULL
(	NULL
32/364	NULL
)	NULL
transgene	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
transgenic	NULL
mice	NULL
lived	NULL
and	NULL
reproduced	NULL
normally	NULL
in	NULL
the	NULL
pathogen-free	NULL
conditions	NULL
.	NULL

The	NULL
thymic	NULL
cellularities	NULL
in	NULL
adult	NULL
animals	NULL
were	NULL
normal	NULL
.	NULL

The	NULL
CD4/CD	NULL
#	NULL
8-positive	NULL
cell	NULL
ratio	NULL
and	NULL
TCR	NULL
,	NULL
CD62L	NULL
,	NULL
CD45RB	NULL
,	NULL
and	NULL
CD44	NULL
expressions	NULL
appeared	NULL
normal	NULL
,	NULL
confirming	NULL
the	NULL
results	NULL
reported	NULL
for	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
despite	NULL
efficient	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
,	NULL
T	NULL
cell	NULL
intrathymic	NULL
proliferation	NULL
and	NULL
differentiation	NULL
occurred	NULL
normally	NULL
in	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
transgenic	NULL
animals	NULL
,	NULL
similarly	NULL
to	NULL
that	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
transgenic	NULL
animals	NULL
,	NULL
and	NULL
contradicted	NULL
our	NULL
initial	NULL
previsions	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
analysis	NULL
of	NULL
splenocyte	NULL
subsets	NULL
confirmed	NULL
an	NULL
alteration	NULL
of	NULL
the	NULL
B/T	NULL
cell	NULL
ratio	NULL
(	NULL
increased	NULL
in	NULL
the	NULL
Tg	NULL
animals	NULL
)	NULL
and	NULL
of	NULL
the	NULL
CD4/CD8	NULL
T	NULL
cell	NULL
ratio	NULL
(	NULL
the	NULL
numbers	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
lymphocytes	NULL
were	NULL
reduced	NULL
relative	NULL
to	NULL
those	NULL
of	NULL
CD4	NULL
cells	NULL
)	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
IxkBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
the	NULL
CD4	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
popula-tions	NULL
,	NULL
since	NULL
Western	NULL
blot	NULL
analysis	NULL
indicated	NULL
that	NULL
the	NULL
transgene	NULL
was	NULL
produced	NULL
with	NULL
comparable	NULL
efficiencies	NULL
in	NULL
both	NULL
T	NULL
cell	NULL
populations	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6445	NULL
A	NULL
A	NULL
Ala.	NULL
(	NULL
32-36	NULL
)	NULL
MAD3	NULL
cDNA	NULL
Not	NULL
!	NULL

BamHI	NULL
Not	NULL
!	NULL

TGA	NULL
--	NULL
-	NULL
-	NULL
mouse	NULL
Ick	NULL
proximal	NULL
promoter	NULL
[	NULL
Z	NULL
pUC	NULL
19	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
FIGURE	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
B	NULL
transgene	NULL
.	NULL

A	NULL
,	NULL
The	NULL
complete	NULL
human	NULL
IxBa	NULL
cDNA	NULL
(	NULL
MAD3	NULL
cDNA	NULL
)	NULL
mutated	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
was	NULL
Mice	NULL
NTg	NULL
Tg3	NULL
Tg	NULL
23	NULL
NTg	NULL
Tg5	NULL
placed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
mouse	NULL
proximal	NULL
Ick	NULL
Smo	NULL
!	NULL

|	NULL
Smith	NULL
.	NULL

Buc	NULL
!	NULL

Hege	NULL
pug	NULL
promoter	NULL
;	NULL
hGH	NULL
gene	NULL
sequences	NULL
were	NULL
added	NULL
to	NULL
confer	NULL
stability	NULL
to	NULL
the	NULL
transcripts	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
termination	NULL
codon	NULL
of	NULL
IxBa	NULL
cDNA	NULL
resulted	NULL
in	NULL
a	NULL
3	NULL
'	NULL
end	NULL
tag	NULL
corresponding	NULL
to	NULL
30	NULL
aa	NULL
at	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
re-	NULL
_	NULL
»	NULL
,	NULL
a-	NULL
58000	NULL
sulting	NULL
transgenic	NULL
protein	NULL
.	NULL

Generation	NULL
of	NULL
transgenic	NULL
mice	NULL
and	NULL
Southern	NULL
blot	NULL
genotyping	NULL
of	NULL
tail	NULL
DNA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
Equal	NULL
amounts	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
50	NULL
pug	NULL
)	NULL
prepared	NULL
from	NULL
transgenic	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
control	NULL
(	NULL
NTg	NULL
)	NULL
thymocytes	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
an	NULL
mAb	NULL
directed	NULL
against	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
human	NULL
IxBa	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
WT	NULL
IxBa	NULL
)	NULL
and	NULL
transgenic	NULL
(	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
)	NULL
IxBa	NULL
proteins	NULL
are	NULL
indi-	NULL
C	NULL
cated	NULL
by	NULL
arrows	NULL
.	NULL

C	NULL
,	NULL
Equal	NULL
amounts	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
transgenic	NULL
thymocytes	NULL
,	NULL
splenic	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Only	NULL
the	NULL
major	NULL
form	NULL
of	NULL
the	NULL
transgenic	NULL
IxBa	NULL
is	NULL
shown	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

D	NULL
,	NULL
Thymocytes	NULL
of	NULL
transgenic	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
control	NULL
(	NULL
NTg	NULL
)	NULL
mice	NULL
were	NULL
cultured	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Ten	NULL
mi-crograms	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
NF-KB	NULL
by	NULL
EMSA	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
major	NULL
inducible	NULL
complex	NULL
pSQ/ReIA	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Cells	NULL
D	NULL
Mice	NULL
PMA/ionomycin	NULL
WT	NULL
IkBo	NULL
»	NULL
IxBa32/36A	NULL
-p	NULL
WT	NULL
IxBo	NULL
-p	NULL
Wk	NULL
,	NULL
|	NULL
<	NULL
-	NULL
45000	NULL
m	NULL
om	NULL
wnt	NULL
wan	NULL
~	NULL
»	NULL
<	NULL
-	NULL
35000	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Thymocytes	NULL
_	NULL
T	NULL
cells	NULL
B	NULL
cells	NULL
wite	NULL
Pid	NULL
1	NULL
2	NULL
3	NULL
NTg	NULL
Tg	NULL
3	NULL
Tg	NULL
23	NULL
NTg	NULL
Tg	NULL
5	NULL
o	NULL
o	NULL
r	NULL
e	NULL
[	NULL
«	NULL
-	NULL
p50/ReIA	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
inhibits	NULL
mitogen-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
To	NULL
analyze	NULL
whether	NULL
the	NULL
T	NULL
cells	NULL
expressing	NULL
the	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
transgene	NULL
are	NULL
able	NULL
to	NULL
respond	NULL
normally	NULL
to	NULL
mitogenic	NULL
signals	NULL
,	NULL
we	NULL
realized	NULL
ex	NULL
vivo	NULL
proliferation	NULL
assays	NULL
with	NULL
T	NULL
cells	NULL
purified	NULL
from	NULL
control	NULL
and	NULL
transgenic	NULL
littermate	NULL
spleens	NULL
and	NULL
from	NULL
thymocytes	NULL
.	NULL

A	NULL
48-h	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
evidenced	NULL
a	NULL
strong	NULL
decrease	NULL
in	NULL
the	NULL
proliferative	NULL
response	NULL
in	NULL
both	NULL
line	NULL
3	NULL
and	NULL
line	NULL
5	NULL
animals	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
their	NULL
respective	NULL
control	NULL
littermates	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
proliferative	NULL
failure	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
was	NULL
noticeably	NULL
stronger	NULL
in	NULL
the	NULL
5	NULL
line	NULL
.	NULL

At	NULL
72	NULL
h	NULL
of	NULL
cell	NULL
culture	NULL
,	NULL
the	NULL
prolif-	NULL
erative	NULL
defect	NULL
was	NULL
even	NULL
stronger	NULL
in	NULL
the	NULL
5	NULL
line	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
decreased	NULL
in	NULL
the	NULL
3	NULL
line	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
residual	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
detected	NULL
in	NULL
the	NULL
Tg	NULL
3	NULL
line	NULL
in	NULL
EMSA	NULL
experiments	NULL
was	NULL
sufficient	NULL
to	NULL
rescue	NULL
the	NULL
proliferation	NULL
failure	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
thymocytes	NULL
from	NULL
the	NULL
transgenic	NULL
and	NULL
control	NULL
animals	NULL
proliferated	NULL
in	NULL
a	NULL
comparable	NULL
manner	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
check	NULL
whether	NULL
addition	NULL
of	NULL
IL-2	NULL
or	NULL
of	NULL
stimulants	NULL
that	NULL
result	NULL
in	NULL
stabilization	NULL
of	NULL
IL-2	NULL
could	NULL
rescue	NULL
the	NULL
proliferative	NULL
response	NULL
in	NULL
the	NULL
5	NULL
line	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
cell	NULL
activation	NULL
with	NULL
immobilized	NULL
CD3-specific	NULL
Abs	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
immobilized	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6446	NULL
T	NULL
CELL	NULL
ACTIVATION	NULL
AND	NULL
DEVELOPMENT	NULL
IN	NULL
IxBa	NULL
TRANSGENIC	NULL
MICE	NULL
48h	NULL
72h	NULL
\	NULL
\	NULL
50	NULL
4	NULL
F	NULL
40	NULL
{	NULL
30	NULL
-	NULL
4	NULL
20	NULL
4	NULL
g	NULL
NTg	NULL
10	NULL
4	NULL
“	NULL
Vim	NULL
.	NULL

Ml	NULL
-An	NULL
|	NULL
Tg	NULL
5	NULL
NTg	NULL
Tg	NULL
5	NULL
fZops	NULL
coas	NULL
l	NULL
mo	NULL
FIGURE	NULL
2	NULL
.	NULL

Proliferation	NULL
of	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
splenic	NULL
T	NULL
cells	NULL
.	NULL

Splenic	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
(	NULL
NTg	NULL
)	NULL
and	NULL
line	NULL
5	NULL
transgenic	NULL
mice	NULL
(	NULL
Tg5	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
48	NULL
and	NULL
72	NULL
h	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
;	NULL
with	NULL
immobilized	NULL
Abs	NULL
specific	NULL
for	NULL
CD3	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
for	NULL
CD3	NULL
and	NULL
for	NULL
CD28	NULL
(	NULL
dashed	NULL
bars	NULL
)	NULL
,	NULL
or	NULL
for	NULL
CD3	NULL
plus	NULL
IL-2	NULL
(	NULL
pale	NULL
gray	NULL
bars	NULL
)	NULL
;	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
gray	NULL
bars	NULL
)	NULL
at	NULL
the	NULL
concentrations	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
*HJthymidine	NULL
incorporation	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
arithmetic	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
for	NULL
three	NULL
control	NULL
and	NULL
three	NULL
transgenic	NULL
mice	NULL
.	NULL

[	NULL
Fops	NULL
+1L-2	NULL
[	NULL
RJ	NULL
PMA	NULL
+	NULL
iono	NULL
I	NULL
CD28-specific	NULL
Abs	NULL
.	NULL

The	NULL
results	NULL
of	NULL
one	NULL
characteristic	NULL
experiment	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Clearly	NULL
,	NULL
neither	NULL
CD28	NULL
costimulus	NULL
nor	NULL
exogenous	NULL
IL-2	NULL
was	NULL
able	NULL
to	NULL
rescue	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
Tg	NULL
5	NULL
mice	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
proliferation	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
IL-2	NULL
production	NULL
.	NULL

This	NULL
result	NULL
confirmed	NULL
the	NULL
findings	NULL
of	NULL
Boothby	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
other	NULL
mitogenic	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-7	NULL
and	NULL
IL-4	NULL
,	NULL
also	NULL
did	NULL
not	NULL
rescue	NULL
the	NULL
proliferative	NULL
response	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
transgenic	NULL
T	NULL
cells	NULL
produce	NULL
normal	NULL
amounts	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
IL-2	NULL
acts	NULL
as	NULL
the	NULL
principal	NULL
auto-	NULL
and	NULL
paracrine	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
.	NULL

In	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
suggested	NULL
a	NULL
central	NULL
role	NULL
for	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
IL-2	NULL
and	NULL
the	NULL
inducible	NULL
IL-2Ra	NULL
(	NULL
24	NULL
,	NULL
48-50	NULL
)	NULL
.	NULL

IL-2	NULL
and	NULL
IL-2Ra	NULL
are	NULL
normally	NULL
produced	NULL
by	NULL
T	NULL
lymphocytes	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
signals	NULL
such	NULL
as	NULL
TCR	NULL
triggering	NULL
or	NULL
phorbol	NULL
ester	NULL
treatment	NULL
in	NULL
association	NULL
with	NULL
calcium	NULL
influx	NULL
inducers	NULL
.	NULL

In	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
IL-2	NULL
production	NULL
was	NULL
reduced	NULL
consequent	NULL
to	NULL
NF-KB	NULL
inhibition	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
measure	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
mitogen-activated	NULL
line	NULL
5	NULL
and	NULL
control	NULL
T	NULL
splenocytes	NULL
to	NULL
secrete	NULL
IL-2	NULL
we	NULL
collected	NULL
their	NULL
supernatants	NULL
and	NULL
tested	NULL
their	NULL
capacity	NULL
to	NULL
activate	NULL
proliferation	NULL
of	NULL
the	NULL
CTLL-2	NULL
cell	NULL
line	NULL
that	NULL
proliferates	NULL
in	NULL
a	NULL
dose-response	NULL
manner	NULL
to	NULL
IL-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
IL-2	NULL
production	NULL
were	NULL
observed	NULL
between	NULL
transgenic	NULL
and	NULL
nontransgenic	NULL
T	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
IL-2	NULL
was	NULL
secreted	NULL
normally	NULL
by	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
transgenic	NULL
mice	NULL
.	NULL

This	NULL
result	NULL
further	NULL
indicated	NULL
that	NULL
the	NULL
proliferative	NULL
failure	NULL
of	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
IL-2	NULL
secretion	NULL
and	NULL
confirmed	NULL
the	NULL
results	NULL
of	NULL
Doi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
,	NULL
who	NULL
showed	NULL
that	NULL
RelA-/-	NULL
T	NULL
cells	NULL
produce	NULL
IL-2	NULL
,	NULL
but	NULL
present	NULL
a	NULL
reduced	NULL
mitogenic	NULL
response	NULL
.	NULL

The	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
IL-2R	NULL
(	NULL
CD25	NULL
)	NULL
is	NULL
another	NULL
potential	NULL
target	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
48	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
proliferative	NULL
defect	NULL
was	NULL
due	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
CD25	NULL
expression	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
1000	NULL
900	NULL
7	NULL
800	NULL
7	NULL
700	NULL
7	NULL
600	NULL
7	NULL
500	NULL
4	NULL
IL-2	NULL
(	NULL
ng/ml	NULL
)	NULL
400	NULL
{	NULL
300	NULL
7	NULL
200	NULL
{	NULL
100	NULL
4	NULL
NTg	NULL
Tg5	NULL
NTg	NULL
Tg5	NULL
CD3	NULL
CD3+CD28	NULL
FIGURE	NULL
3	NULL
.	NULL

IL-2	NULL
production	NULL
by	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
32/36	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

IL-2	NULL
production	NULL
by	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
mice	NULL
(	NULL
NTg	NULL
;	NULL
dashed	NULL
bars	NULL
)	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
Tg5	NULL
;	NULL
black	NULL
bars	NULL
)	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
CTLL-2	NULL
proliferation	NULL
assay	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
triplicate	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plate-bound	NULL
anti-CD3	NULL
Abs	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
Abs	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Supernatants	NULL
from	NULL
these	NULL
cell	NULL
cultures	NULL
were	NULL
assayed	NULL
for	NULL
IL-2	NULL
by	NULL
CTLL-2	NULL
proliferation	NULL
and	NULL
were	NULL
quantitated	NULL
by	NULL
comparison	NULL
to	NULL
CTLL-2	NULL
proliferation	NULL
in	NULL
medium	NULL
containing	NULL
known	NULL
doses	NULL
of	NULL
IL-2	NULL
protein	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
value	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

expression	NULL
of	NULL
CD25	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

When	NULL
treated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
conditions	NULL
under	NULL
which	NULL
proliferation	NULL
of	NULL
Tg	NULL
5	NULL
T	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
>	NULL
90	NULL
%	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
control	NULL
cells	NULL
)	NULL
,	NULL
CD25	NULL
was	NULL
induced	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
in	NULL
both	NULL
transgenic	NULL
and	NULL
control	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
proliferation	NULL
of	NULL
Tg	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
explainable	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
or	NULL
its	NULL
receptor	NULL
.	NULL

IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
Tg	NULL
T	NULL
cells	NULL
fail	NULL
to	NULL
produce	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IFN-y	NULL
To	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
cytokines	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
secretion	NULL
of	NULL
IFN-y	NULL
,	NULL
which	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
an	NULL
intronic	NULL
binding	NULL
site	NULL
for	NULL
c-Rel	NULL
(	NULL
51	NULL
)	NULL
and	NULL
the	NULL
secretion	NULL
of	NULL
which	NULL
by	NULL
the	NULL
Th1	NULL
subset	NULL
of	NULL
T	NULL
cells	NULL
parallels	NULL
that	NULL
of	NULL
IL-2	NULL
.	NULL

A	NULL
typical	NULL
result	NULL
obtained	NULL
by	NULL
ELISA	NULL
demonstrated	NULL
that	NULL
IFN-y	NULL
production	NULL
by	NULL
Tg	NULL
T	NULL
cells	NULL
was	NULL
10	NULL
times	NULL
less	NULL
than	NULL
that	NULL
by	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

The	NULL
RT-PCR	NULL
measurement	NULL
further	NULL
confirmed	NULL
that	NULL
IL-2	NULL
induction	NULL
was	NULL
normal	NULL
in	NULL
Tg	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
TNF-a	NULL
production	NULL
by	NULL
RT-PCR	NULL
show	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
mRNA	NULL
levels	NULL
between	NULL
Tg	NULL
and	NULL
control	NULL
mice	NULL
,	NULL
although	NULL
this	NULL
gene	NULL
was	NULL
previously	NULL
described	NULL
as	NULL
possessing	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
its	NULL
promoter	NULL
domains	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Curiously	NULL
,	NULL
IL-4	NULL
and	NULL
IL-10	NULL
production	NULL
was	NULL
inhibited	NULL
as	NULL
shown	NULL
by	NULL
RT-PCR	NULL
and	NULL
ELISA	NULL
of	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
absence	NULL
of	NULL
IL-4	NULL
production	NULL
was	NULL
due	NULL
to	NULL
a	NULL
down-regulation	NULL
of	NULL
the	NULL
Th2	NULL
cell	NULL
population	NULL
or	NULL
to	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
IL-4	NULL
promoter	NULL
,	NULL
we	NULL
analyzed	NULL
IL-4	NULL
production	NULL
and	NULL
IL-4	NULL
promoter	NULL
activation	NULL
in	NULL
EL4	NULL
cells	NULL
(	NULL
a	NULL
murine	NULL
Th2-type	NULL
cell	NULL
line	NULL
)	NULL
.	NULL

Stable	NULL
transfection	NULL
of	NULL
ELA	NULL
cells	NULL
with	NULL
(	NULL
32/36	NULL
)	NULL
vectors	NULL
(	NULL
tagged	NULL
and	NULL
untagged	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
IL-4	NULL
secretion	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
two	NULL
murine	NULL
IL-4	NULL
promoter	NULL
constructs	NULL
was	NULL
also	NULL
significantly	NULL
inhibited	NULL
in	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
clones	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
,	NULL
especially	NULL
the	NULL
construct	NULL
containing	NULL
sequences	NULL
upstream	NULL
from	NULL
the	NULL
P1	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

Since	NULL
the	NULL
CD44*®	NULL
``	NULL
*	NULL
T	NULL
cell	NULL
population	NULL
was	NULL
normally	NULL
detected	NULL
in	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
Tg	NULL
mice	NULL
,	NULL
our	NULL
results	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
1300	NULL
1200	NULL
11004	NULL
1000	NULL
900	NULL
E	NULL
800	NULL
g	NULL
700	NULL
£	NULL
600	NULL
{	NULL
Z	NULL
500	NULL
400	NULL
300	NULL
{	NULL
200	NULL
4	NULL
100	NULL
4	NULL
NTg	NULL
Tg5	NULL
CD3	NULL
CD3+CD28	NULL
C	NULL
IL-2	NULL
B	NULL
Actin	NULL
IL-4	NULL
B	NULL
Actin	NULL
IL-10	NULL
INFy	NULL
B	NULL
Actin	NULL
TNFo	NULL
.	NULL

B	NULL
Actin	NULL
6447	NULL
IL-4	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

sine	NULL
NTg	NULL
Tg5	NULL
NTg	NULL
Tg5	NULL
CD3	NULL
CD3+CD28	NULL
IL-2	NULL
B	NULL
Actin	NULL
IL-4	NULL
B	NULL
Actin	NULL
IL-10	NULL
|W	NULL
B	NULL
Actin	NULL
INFy	NULL
B	NULL
Actin	NULL
TNFo	NULL
.	NULL

B	NULL
Actin	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Cytokine	NULL
production	NULL
by	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

IFN-y	NULL
(	NULL
4	NULL
)	NULL
and	NULL
IL-4	NULL
(	NULL
B	NULL
)	NULL
production	NULL
by	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
mice	NULL
(	NULL
NT	NULL
g	NULL
;	NULL
dashed	NULL
bars	NULL
)	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
Tg5	NULL
;	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
triplicate	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plate-bound	NULL
anti-CD3	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
Abs	NULL
.	NULL

Supernatants	NULL
from	NULL
these	NULL
cultures	NULL
were	NULL
assayed	NULL
by	NULL
ELISA	NULL
and	NULL
were	NULL
quantified	NULL
by	NULL
comparison	NULL
to	NULL
standard	NULL
IFN-y	NULL
or	NULL
IL-4	NULL
proteins	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
value	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

C	NULL
,	NULL
Analysis	NULL
of	NULL
cytokine	NULL
mRNA	NULL
productions	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
mice	NULL
(	NULL
NTg	NULL
)	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
Tg	NULL
5	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
RT-PCR	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
T	NULL
cells	NULL
cultured	NULL
for	NULL
4	NULL
h	NULL
(	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IFN-y	NULL
)	NULL
or	NULL
12	NULL
h	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
1	NULL
)	NULL
,	NULL
anti-CD3	NULL
Ab	NULL
(	NULL
2	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
various	NULL
genes	NULL
,	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
leff	NULL
.	NULL

The	NULL
B-actin	NULL
gene	NULL
constituted	NULL
the	NULL
internal	NULL
control	NULL
.	NULL

suggest	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
IL-4	NULL
production	NULL
by	NULL
these	NULL
mice	NULL
is	NULL
due	NULL
to	NULL
a	NULL
deficient	NULL
activation	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
rather	NULL
than	NULL
to	NULL
an	NULL
underdevel-opment	NULL
of	NULL
the	NULL
Th2	NULL
subpopulation	NULL
.	NULL

Enhanced	NULL
apoptosis	NULL
of	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
Tg	NULL
T	NULL
cells	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
inhibition	NULL
(	NULL
53	NULL
)	NULL
and	NULL
stimulation	NULL
(	NULL
53-55	NULL
)	NULL
of	NULL
cell	NULL
susceptibility	NULL
to	NULL
apoptosis	NULL
.	NULL

For	NULL
example	NULL
,	NULL
RelA-deficient	NULL
mice	NULL
die	NULL
from	NULL
apoptosis	NULL
of	NULL
embryonic	NULL
hepatocytes	NULL
(	NULL
30	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
the	NULL
splenic	NULL
T	NULL
cell	NULL
lymphopenia	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
proliferative	NULL
response	NULL
in	NULL
ex	NULL
vivo	NULL
experiments	NULL
might	NULL
be	NULL
due	NULL
to	NULL
an	NULL
enhanced	NULL
apoptotic	NULL
susceptibility	NULL
of	NULL
the	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
transgenic	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
death	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
use	NULL
of	NULL
the	NULL
TUNEL	NULL
assay	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
controls	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
40	NULL
%	NULL
increase	NULL
in	NULL
the	NULL
spontaneous	NULL
apoptosis	NULL
of	NULL
line	NULL
5	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
a	NULL
3	NULL
times	NULL
higher	NULL
apoptosis	NULL
after	NULL
48	NULL
h	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
treatment	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
T	NULL
cells	NULL
led	NULL
to	NULL
an	NULL
increased	NULL
apoptosis	NULL
in	NULL
both	NULL
activation	NULL
and	NULL
resting	NULL
conditions	NULL
and	NULL
might	NULL
explain	NULL
in	NULL
part	NULL
the	NULL
strong	NULL
inhibition	NULL
of	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
Tg	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
the	NULL
hypoplasticity	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6448	NULL
T	NULL
CELL	NULL
ACTIVATION	NULL
AND	NULL
DEVELOPMENT	NULL
IN	NULL
IxBa	NULL
TRANSGENIC	NULL
MICE	NULL
16	NULL
14	NULL
{	NULL
12	NULL
1	NULL
_s	NULL
o	NULL
a	NULL
IL-4	NULL
{	NULL
ng/ml	NULL
)	NULL
co	NULL
B8	NULL
fold	NULL
increase	NULL
EL4	NULL
Cell	NULL
Clones	NULL
Control	NULL
13	NULL
19	NULL
4p110-Luc	NULL
Control	NULL
13	NULL
19	NULL
Constructs	NULL
4p575-Luc	NULL
FIGURE	NULL
5	NULL
.	NULL

IL-4	NULL
production	NULL
by	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
ELA	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
,	NULL
Production	NULL
of	NULL
IL-4	NULL
protein	NULL
after	NULL
48	NULL
h	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
stimulation	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
in	NULL
supernatants	NULL
from	NULL
control	NULL
ELA	NULL
cells	NULL
(	NULL
ELA	NULL
)	NULL
,	NULL
EL4	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
tag	NULL
cell	NULL
clone	NULL
(	NULL
B8	NULL
)	NULL
,	NULL
and	NULL
EL4	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
cell	NULL
clones	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
in	NULL
triplicate	NULL
.	NULL

SDs	NULL
represent	NULL
<	NULL
10	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
value	NULL
.	NULL

B	NULL
,	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
IL-4	NULL
promoter	NULL
Luc	NULL
constructs	NULL
4p110-Luc	NULL
or	NULL
4p575-Luc	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Luc	NULL
activity	NULL
was	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
treatment	NULL
of	NULL
control	NULL
cells	NULL
(	NULL
EL4	NULL
)	NULL
and	NULL
EL4	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
cell	NULL
clones	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
fold	NULL
increase	NULL
in	NULL
Luc	NULL
relative	NULL
units	NULL
in	NULL
activated	NULL
cells	NULL
relative	NULL
to	NULL
control	NULL
level	NULL
activities	NULL
.	NULL

The	NULL
relative	NULL
Luc	NULL
activities	NULL
were	NULL
calculated	NULL
from	NULL
six	NULL
independent	NULL
experiments	NULL
.	NULL

SDs	NULL
are	NULL
shown	NULL
with	NULL
vertical	NULL
bars	NULL
.	NULL

Discussion	NULL
In	NULL
an	NULL
attempt	NULL
to	NULL
elucidate	NULL
the	NULL
functions	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

factors	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
,	NULL
we	NULL
have	NULL
developed	NULL
a	NULL
transgenic	NULL
mouse	NULL
model	NULL
in	NULL
which	NULL
a	NULL
dominant-negative	NULL
mutated	NULL
form	NULL
of	NULL
IxBa	NULL
was	NULL
overex-pressed	NULL
in	NULL
thymocytes	NULL
and	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
secondary	NULL
lymphoid	NULL
tissues	NULL
.	NULL

This	NULL
T	NULL
cell-targeted	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
has	NULL
clear	NULL
advantages	NULL
and	NULL
inconveniences	NULL
over	NULL
gene	NULL
disruption	NULL
experiments	NULL
,	NULL
since	NULL
it	NULL
allowed	NULL
inhibition	NULL
of	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
(	NULL
c-Rel-	NULL
and	NULL
RelA-p50	NULL
)	NULL
without	NULL
inducing	NULL
lethality	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
found	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
mice	NULL
over	NULL
the	NULL
age	NULL
of	NULL
6	NULL
wk	NULL
,	NULL
the	NULL
transgenic	NULL
IxBa	NULL
was	NULL
incompletely	NULL
inhibiting	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
in	NULL
the	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
the	NULL
transgenic	NULL
IxBa	NULL
was	NULL
related	NULL
to	NULL
its	NULL
expression	NULL
level	NULL
,	NULL
and	NULL
consequently	NULL
,	NULL
it	NULL
was	NULL
less	NULL
potent	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
than	NULL
in	NULL
thymocytes	NULL
.	NULL

Despite	NULL
these	NULL
differences	NULL
in	NULL
NF-KB	NULL
inhibition	NULL
,	NULL
the	NULL
biological	NULL
effects	NULL
of	NULL
the	NULL
transgene	NULL
were	NULL
detectable	NULL
only	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
observations	NULL
basically	NULL
confirmed	NULL
those	NULL
of	NULL
Boothby	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
and	NULL
Doi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
that	NULL
thymocyte	NULL
cellularities	NULL
and	NULL
intrathymic	NULL
differentiation	NULL
are	NULL
little	NULL
,	NULL
if	NULL
at	NULL
all	NULL
,	NULL
affected	NULL
by	NULL
inhi-	NULL
bition	NULL
of	NULL
NF-KB	NULL
within	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
results	NULL
,	NULL
Es-slinger	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
thymocyte	NULL
cellu-larity	NULL
as	NULL
well	NULL
as	NULL
a	NULL
spectacular	NULL
deficiency	NULL
of	NULL
the	NULL
mature	NULL
single-positive	NULL
thymocytes	NULL
in	NULL
mice	NULL
transgenic	NULL
for	NULL
human	NULL
IxBa	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Further	NULL
investigations	NULL
are	NULL
necessary	NULL
to	NULL
explain	NULL
these	NULL
differences	NULL
in	NULL
thymus	NULL
phenotypes	NULL
.	NULL

Despite	NULL
only	NULL
a	NULL
partial	NULL
NF-KB	NULL
inhibition	NULL
in	NULL
splenic	NULL
T	NULL
cells	NULL
,	NULL
mature	NULL
T	NULL
cell	NULL
subsets	NULL
were	NULL
further	NULL
compromised	NULL
.	NULL

In	NULL
situ	NULL
splenic	NULL
T	NULL
cell	NULL
lymphopenia	NULL
and	NULL
alteration	NULL
of	NULL
the	NULL
CD4/CD8	NULL
ratio	NULL
were	NULL
observed	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
findings	NULL
of	NULL
Boothby	NULL
et	NULL
al	NULL
.	NULL

In	NULL
animals	NULL
transgenic	NULL
for	NULL
IBB	NULL
,	NULL
a	NULL
strong	NULL
T	NULL
cell	NULL
lymphopenia	NULL
was	NULL
also	NULL
obtained	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
normal	NULL
NF-KB	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
homeostasis	NULL
.	NULL

Ex	NULL
vivo	NULL
proliferation	NULL
studies	NULL
showed	NULL
that	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
transgenic	NULL
T	NULL
cells	NULL
failed	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
,	NULL
and	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
T	NULL
cells	NULL
from	NULL
c-Rel-deficient	NULL
mice	NULL
,	NULL
addition	NULL
of	NULL
IL-2	NULL
to	NULL
incubation	NULL
medium	NULL
did	NULL
not	NULL
restore	NULL
proliferation	NULL
despite	NULL
normal	NULL
expression	NULL
of	NULL
CD25	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
previously	NULL
reported	NULL
for	NULL
T	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
IxBa	NULL
{	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
failed	NULL
to	NULL
produce	NULL
IL-2	NULL
,	NULL
while	NULL
IxkBa	NULL
(	NULL
32/36	NULL
)	NULL
T	NULL
cells	NULL
produced	NULL
normal	NULL
amounts	NULL
of	NULL
this	NULL
growth	NULL
factor	NULL
.	NULL

This	NULL
difference	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
in	NULL
I	NULL
«	NULL
xBa	NULL
(	NULL
32/36	NULL
)	NULL
T	NULL
lymphocytes	NULL
,	NULL
NF-KB	NULL
activation	NULL
was	NULL
only	NULL
partially	NULL
inhibited	NULL
.	NULL

In	NULL
every	NULL
case	NULL
,	NULL
these	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
defect	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
homeostasis	NULL
is	NULL
not	NULL
attributable	NULL
to	NULL
a	NULL
deficiency	NULL
of	NULL
IL-2	NULL
or	NULL
its	NULL
inducible	NULL
receptor	NULL
,	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
IL-2	NULL
signal	NULL
transduction	NULL
.	NULL

Thus	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
molecular	NULL
events	NULL
downstream	NULL
of	NULL
IL-2R	NULL
,	NULL
but	NULL
the	NULL
mechanism	NULL
and	NULL
the	NULL
potential	NULL
gene	NULL
targets	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
IL-2	NULL
growth	NULL
signaling	NULL
remain	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
confirmed	NULL
that	NULL
NF-KB	NULL
is	NULL
critical	NULL
for	NULL
apoptotic	NULL
protection	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Fas	NULL
ligand	NULL
and	NULL
antiapoptotic	NULL
gene	NULL
products	NULL
such	NULL
as	NULL
Bel-2	NULL
and	NULL
Bel-x	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
apoptosis	NULL
and	NULL
should	NULL
be	NULL
examined	NULL
(	NULL
58-63	NULL
)	NULL
.	NULL

IL-2	NULL
and	NULL
CD25	NULL
are	NULL
produced	NULL
in	NULL
T	NULL
cells	NULL
during	NULL
the	NULL
early	NULL
stage	NULL
of	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
produced	NULL
IL-2	NULL
and	NULL
CD25	NULL
normally	NULL
,	NULL
our	NULL
observations	NULL
indicated	NULL
that	NULL
partial	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
did	NULL
not	NULL
block	NULL
the	NULL
initial	NULL
G	NULL
,	NULL
-G	NULL
,	NULL
transition	NULL
.	NULL

However	NULL
,	NULL
[	NULL
°HJthymidine	NULL
incorporation	NULL
was	NULL
strongly	NULL
inhibited	NULL
(	NULL
as	NULL
was	NULL
bromodeoxyuridine	NULL
incorporation	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
full	NULL
NF-KB	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
cycle	NULL
G	NULL
,	NULL
/S	NULL
progression	NULL
.	NULL

Although	NULL
little	NULL
is	NULL
known	NULL
about	NULL
NF-KB	NULL
involvement	NULL
in	NULL
cell	NULL
cycle	NULL
regulation	NULL
,	NULL
several	NULL
reports	NULL
demonstrated	NULL
that	NULL
NF-KB	NULL
activity	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
NF-kB	NULL
and	NULL
CDKs	NULL
through	NULL
the	NULL
p300	NULL
and	NULL
CREB-binding	NULL
protein	NULL
coactivators	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
coordination	NULL
of	NULL
transcriptional	NULL
activation	NULL
with	NULL
cell	NULL
cycle	NULL
progression	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
.	NULL

NF-KB	NULL
could	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
activity	NULL
or	NULL
transcription	NULL
of	NULL
proteins	NULL
controlling	NULL
directly	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
transition	NULL
.	NULL

Indeed	NULL
,	NULL
Bash	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
c-Rel	NULL
expression	NULL
leads	NULL
to	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
by	NULL
changing	NULL
the	NULL
activation	NULL
and/or	NULL
expression	NULL
of	NULL
E2F	NULL
,	NULL
Cdk2	NULL
,	NULL
p53	NULL
,	NULL
and	NULL
p21	NULL
``	NULL
~*	NULL
'	NULL
``	NULL
proteins	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
67	NULL
)	NULL
.	NULL

IL-2-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
down-regulation	NULL
of	NULL
the	NULL
cyclin-CDK	NULL
inhibitor	NULL
p27	NULL
(	NULL
68	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
one	NULL
might	NULL
speculate	NULL
that	NULL
NF-B	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
phase	NULL
transition	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
either	NULL
transcriptionally	NULL
controlling	NULL
or	NULL
functionally	NULL
interacting	NULL
with	NULL
the	NULL
cell	NULL
cycle	NULL
molecular	NULL
machinery	NULL
.	NULL

Although	NULL
normal	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
32/36	NULL
)	NULL
cells	NULL
indicated	NULL
that	NULL
the	NULL
low	NULL
amounts	NULL
of	NULL
NFE-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
were	NULL
sufficient	NULL
to	NULL
induce	NULL
some	NULL
of	NULL
the	NULL
NF-KB	NULL
gene	NULL
targets	NULL
,	NULL
the	NULL
important	NULL
biological	NULL
consequences	NULL
of	NULL
partial	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
(	NULL
lack	NULL
of	NULL
proliferation	NULL
,	NULL
apoptosis	NULL
)	NULL
indicated	NULL
that	NULL
several	NULL
genes	NULL
were	NULL
down-regulated	NULL
.	NULL

Among	NULL
those	NULL
genes	NULL
,	NULL
Th1	NULL
subset	NULL
cytokines	NULL
such	NULL
as	NULL
IFN-y	NULL
,	NULL
and	NULL
Th2	NULL
subset	NULL
cytokines	NULL
such	NULL
as	NULL
IL-4	NULL
and	NULL
IL-10	NULL
were	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
transcriptionally	NULL
inhibited	NULL
.	NULL

The	NULL
down-regulation	NULL
of	NULL
IL-4	NULL
by	NULL
inhibition	NULL
of	NULL
NF-B	NULL
activity	NULL
was	NULL
mimicked	NULL
in	NULL
vitro	NULL
by	NULL
stable	NULL
transfection	NULL
of	NULL
EL-4	NULL
cells	NULL
by	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
reduction	NULL
of	NULL
Th2	NULL
cytokine	NULL
expression	NULL
resulted	NULL
from	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
this	NULL
gene	NULL
and	NULL
not	NULL
on	NULL
a	NULL
lack	NULL
of	NULL
the	NULL
Th2	NULL
cell	NULL
subtype	NULL
.	NULL

IL-4	NULL
down-regulation	NULL
was	NULL
surprising	NULL
,	NULL
since	NULL
the	NULL
murine	NULL
IL-4	NULL
promoter	NULL
is	NULL
not	NULL
known	NULL
to	NULL
possess	NULL
high	NULL
affinity	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

The	NULL
human	NULL
IL-4	NULL
promoter	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
repressed	NULL
by	NULL
RelA-p50	NULL
through	NULL
the	NULL
P1	NULL
sequence	NULL
,	NULL
but	NULL
this	NULL
did	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
the	NULL
case	NULL
for	NULL
the	NULL
murine	NULL
promoter	NULL
(	NULL
69	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
murine	NULL
and	NULL
human	NULL
IL-4	NULL
genes	NULL
are	NULL
not	NULL
regulated	NULL
identically	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
.	NULL

Our	NULL
results	NULL
obtained	NULL
both	NULL
in	NULL
vitro	NULL
(	NULL
ELA	NULL
cells	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
indicated	NULL
that	NULL
even	NULL
partial	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
activities	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
down-regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
,	NULL
suggesting	NULL
that	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
positive	NULL
regulation	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
in	NULL
mice	NULL
.	NULL

Fur-thermore	NULL
,	NULL
an	NULL
increased	NULL
NF-KB	NULL
activity	NULL
obtained	NULL
in	NULL
NF-	NULL
«	NULL
B2	NULL
'~	NULL
mice	NULL
led	NULL
to	NULL
increased	NULL
IL-4	NULL
and	NULL
IL-10	NULL
production	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
necessary	NULL
to	NULL
explain	NULL
the	NULL
mechanism	NULL
of	NULL
IL-4	NULL
gene	NULL
regulation	NULL
by	NULL
NF-KB	NULL
.	NULL

IL-10	NULL
possesses	NULL
several	NULL
«	NULL
B	NULL
sites	NULL
far	NULL
upstream	NULL
of	NULL
its	NULL
transcriptional	NULL
start	NULL
,	NULL
but	NULL
its	NULL
transcriptional	NULL
regulation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
never	NULL
been	NULL
reported	NULL
(	NULL
71	NULL
)	NULL
.	NULL

A	NULL
previous	NULL
study	NULL
of	NULL
TNE-	NULL
@	NULL
gene	NULL
regulation	NULL
demonstrated	NULL
that	NULL
multimers	NULL
of	NULL
TNF-a	NULL
«	NULL
B	NULL
sites	NULL
could	NULL
confer	NULL
inducibility	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
in	NULL
a	NULL
B	NULL
,	NULL
but	NULL
not	NULL
in	NULL
a	NULL
T	NULL
,	NULL
cell	NULL
line	NULL
(	NULL
72	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
further	NULL
demonstrated	NULL
that	NULL
NF-B	NULL
is	NULL
not	NULL
required	NULL
for	NULL
TNF-	NULL
«	NULL
induction	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Finally	NULL
,	NULL
another	NULL
gene	NULL
known	NULL
to	NULL
be	NULL
critically	NULL
dependent	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
namely	NULL
IxBa	NULL
,	NULL
was	NULL
down-regulated	NULL
in	NULL
IxBa	NULL
(	NULL
32/36A	NULL
)	NULL
T	NULL
cells	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
mice	NULL
line	NULL
producing	NULL
the	NULL
highest	NULL
amounts	NULL
of	NULL
the	NULL
transgene	NULL
.	NULL

Besides	NULL
IL-2	NULL
,	NULL
other	NULL
genes	NULL
known	NULL
to	NULL
possess	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
their	NULL
promoter	NULL
region	NULL
were	NULL
not	NULL
down-regulated	NULL
in	NULL
IxBa	NULL
(	NULL
32/36	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
attenuated	NULL
nuclear	NULL
import	NULL
of	NULL
RelA	NULL
and	NULL
c-Rel	NULL
dimers	NULL
in	NULL
splenic	NULL
T	NULL
cells	NULL
seems	NULL
to	NULL
differentially	NULL
affect	NULL
transcription	NULL
of	NULL
different	NULL
target	NULL
genes	NULL
.	NULL

These	NULL
results	NULL
highlight	NULL
our	NULL
ignorance	NULL
of	NULL
the	NULL
real	NULL
mechanism	NULL
of	NULL
in	NULL
vivo	NULL
regulation	NULL
of	NULL
transcription	NULL
through	NULL
particular	NULL
B	NULL
sites	NULL
in	NULL
individual	NULL
genes	NULL
and	NULL
suggest	NULL
that	NULL
many	NULL
genes	NULL
with	NULL
«	NULL
B	NULL
sites	NULL
could	NULL
be	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
independent	NULL
or	NULL
dose	NULL
dependent	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
many	NULL
genes	NULL
could	NULL
be	NULL
indirectly	NULL
regulated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
by	NULL
transcriptional	NULL
control	NULL
of	NULL
other	NULL
genes	NULL
specific	NULL
for	NULL
transcription	NULL
factors	NULL
.	NULL

Although	NULL
many	NULL
other	NULL
biological	NULL
consequences	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
in	NULL
T	NULL
cells	NULL
remain	NULL
to	NULL
be	NULL
investigated	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
demonstrated	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
in	NULL
normal	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
homeostasis	NULL
,	NULL
and	NULL
production	NULL
of	NULL
cytokines	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Catherine	NULL
Amarger	NULL
for	NULL
helping	NULL
with	NULL
the	NULL
graphical	NULL
processing	NULL
of	NULL
the	NULL
data	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
Dr.	NULL
Leo	NULL
Lee	NULL
for	NULL
providing	NULL
B	NULL
oligonucleo-tides	NULL
,	NULL
to	NULL
Dr.	NULL
Carl	NULL
June	NULL
for	NULL
the	NULL
anti	NULL
CD28	NULL
PV-I	NULL
(	NULL
6Ga	NULL
)	NULL
Ab	NULL
,	NULL
to	NULL
Dr.	NULL
William	NULL
Paul	NULL
for	NULL
IL-4	NULL
constructs	NULL
,	NULL
and	NULL
to	NULL
Dr.	NULL
Ron	NULL
Hay	NULL
for	NULL
IxBa-specific	NULL
mAb	NULL
.	NULL

We	NULL
thank	NULL
Stéphanie	NULL
Gaillard	NULL
and	NULL
Christophe	NULL
Parizot	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
especially	NULL
thank	NULL
Prof.	NULL
Patrice	NULL
Debré	NULL
for	NULL
constant	NULL
encouragement	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Jamieson	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1991	NULL
.	NULL

Physiologic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:416	NULL
.	NULL

2	NULL
.	NULL

Sen	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Venkataraman	NULL
,	NULL
Y.	NULL
Shinkai	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
S.	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1995	NULL
.	NULL

Expression	NULL
and	NULL
induction	NULL
of	NULL
nuclear	NULL
factor-B-related	NULL
proteins	NULL
in	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:3213	NULL
.	NULL

3	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-KB	NULL
and	NULL
IKB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

4	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

5	NULL
.	NULL

Komer	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
and	NULL
P.	NULL
Debré	NULL
.	NULL

1991	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
human	NULL
thymocytes	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

181:80	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

6449	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Dargemont	NULL
,	NULL
V.	NULL
Ferreira	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
P.	NULL
Debré	NULL
,	NULL
M.	NULL
Raphael	NULL
,	NULL
and	NULL
M.	NULL
Kérner	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
Rel-A	NULL
and	NULL
c-Rel	NULL
protein	NULL
complexes	NULL
are	NULL
differentially	NULL
distributed	NULL
within	NULL
human	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2585.	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
Rel/NF-	NULL
«	NULL
B	NULL
activities	NULL
in	NULL
mouse	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

Oncogene	NULL
9:3289.	NULL
.	NULL

Ivanov	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
R.	NULL
Ceredig	NULL
.	NULL

1992	NULL
.	NULL

Transcription	NULL
factors	NULL
in	NULL
mouse	NULL
fetal	NULL
thymus	NULL
development	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

4:729.	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.-S.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-KB	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1992	NULL
.	NULL

I	NULL
«	NULL
B	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-KB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-KB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
NF-KB	NULL
activation	NULL
,	NULL
enhanced	NULL
granulopoiesis	NULL
,	NULL
and	NULL
neonatal	NULL
lethality	NULL
in	NULL
cient	NULL
mice	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2736	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-KB1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-B	NULL
.	NULL

Cell	NULL
78:773	NULL
.	NULL

Li	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
R.	NULL
Dai	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Longo	NULL
1995	NULL
.	NULL

Inactivation	NULL
of	NULL
NF-KB	NULL
inhibitor	NULL
I	NULL
«	NULL
Ba	NULL
:	NULL
ubiquitin-dependent	NULL
proteolysis	NULL
and	NULL
its	NULL
degradation	NULL
product	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

215:292	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
M.	NULL
Delhase	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IKB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKa	NULL
and	NULL
IKK	NULL
,	NULL
necessary	NULL
for	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Cell	NULL
91:243	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
B.	NULL
W.	NULL
Murray	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
B.	NULL
L.	NULL
Bennett	NULL
,	NULL
J.	NULL
W.	NULL
Li	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

Young	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
and	NULL
M.	NULL
Mann	NULL
.	NULL

1997	NULL
.	NULL

IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-Activated	NULL
IxB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Science	NULL
278:860	NULL
.	NULL

Woronicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1997	NULL
.	NULL

IB	NULL
Kinase-B	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
I	NULL
«	NULL
B	NULL
kinase-	NULL
and	NULL
NIK	NULL
.	NULL

Science	NULL
278:866	NULL
.	NULL

Stancovski	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1997	NULL
.	NULL

NF-B	NULL
activation	NULL
:	NULL
the	NULL
IxB	NULL
kinase	NULL
re-vealed	NULL
?	NULL

Cell	NULL
91:299	NULL
.	NULL

Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
requires	NULL
site-specific	NULL
ubiquitination	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11259	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1995	NULL
.	NULL

Mechanistic	NULL
aspects	NULL
of	NULL
NF-KB	NULL
regulation	NULL
:	NULL
the	NULL
emerging	NULL
role	NULL
of	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
.	NULL

Immunity	NULL
3:263	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
,	NULL
H.	NULL
Pahl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IkBa	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IxBa	NULL
proteolysis	NULL
and	NULL
NF-KB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876	NULL
.	NULL

Cai	NULL
,	NULL
Z.	NULL
,	NULL
M.	NULL
Kérner	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
and	NULL
S.	NULL
Chouaib	NULL
.	NULL

1997	NULL
.	NULL

IxBa	NULL
overexpression	NULL
in	NULL
human	NULL
breast	NULL
carcinoma	NULL
MCF7	NULL
cells	NULL
inhibits	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
activation	NULL
but	NULL
not	NULL
tumor	NULL
necrosis	NULL
factor-a-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:96	NULL
.	NULL

Ferreira	NULL
,	NULL
V.	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
and	NULL
M.	NULL
Korner	NULL
.	NULL

1998	NULL
.	NULL

Discrimination	NULL
between	NULL
RelA	NULL
and	NULL
RelB	NULL
transcriptional	NULL
regulation	NULL
by	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:592	NULL
.	NULL

Kontgen	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
J.	NULL
Grumont	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
D.	NULL
Tarlinton	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1995	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
c-re/	NULL
proto-oncogene	NULL
exhibit	NULL
defects	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
,	NULL
humoral	NULL
immunity	NULL
,	NULL
and	NULL
interleukin-2	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1965	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
E.	NULL
I.	NULL
Tuomanen	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-KB	NULL
leads	NULL
to	NULL
multifocal	NULL
defects	NULL
in	NULL
immune	NULL
responses	NULL
.	NULL

Cell	NULL
80:321	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
L.	NULL
Poljak	NULL
,	NULL
E.	NULL
W.	NULL
Shores	NULL
,	NULL
S.	NULL
Epstein	NULL
,	NULL
A.	NULL
Leonardi	NULL
,	NULL
A.	NULL
Grinberg	NULL
,	NULL
T.	NULL
Tran	NULL
,	NULL
T.	NULL
Scharton-Kersten	NULL
,	NULL
M.	NULL
Anver	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-KB/pS52	NULL
present	NULL
with	NULL
defects	NULL
in	NULL
humoral	NULL
responses	NULL
,	NULL
germinal	NULL
center	NULL
reactions	NULL
,	NULL
and	NULL
splenic	NULL
microarchitecture	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:147	NULL
.	NULL

Burkly	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
L.	NULL
Ogata	NULL
,	NULL
C.	NULL
Reilly	NULL
,	NULL
D.	NULL
Marconi	NULL
,	NULL
D.	NULL
Olson	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
R.	NULL
Cate	NULL
,	NULL
and	NULL
D.	NULL
Lo	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
RelB	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
thymic	NULL
medulla	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Nature	NULL
373:531	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
S.	NULL
K.	NULL
Durham	NULL
,	NULL
D.	NULL
S.	NULL
Barton	NULL
,	NULL
C.	NULL
A.	NULL
Rizzo	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
S.	NULL
A.	NULL
Lira	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1995	NULL
.	NULL

Multiorgan	NULL
inflammation	NULL
and	NULL
hematopoietic	NULL
abnormalities	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
RelB	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

Cell	NULL
80:331	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degeneration	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-B	NULL
.	NULL

Nature	NULL
376:167	NULL
.	NULL

Doi	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
T.	NULL
Takahashi	NULL
,	NULL
O.	NULL
Taguchi	NULL
,	NULL
T.	NULL
Azumza	NULL
,	NULL
and	NULL
Y.	NULL
Obata	NULL
.	NULL

1997	NULL
.	NULL

NF-kB	NULL
RelA-deficient	NULL
lymphocytes	NULL
:	NULL
normal	NULL
development	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
impaired	NULL
production	NULL
of	NULL
IgA	NULL
and	NULL
IgG1	NULL
and	NULL
reduced	NULL
proliferative	NULL
responses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:953	NULL
.	NULL

Tan	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor-a-chain	NULL
gene	NULL
promoter	NULL
by	NULL
c-Rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067	NULL
.	NULL

Garoufalis	NULL
,	NULL
E.	NULL
,	NULL
I.	NULL
Kwan	NULL
,	NULL
R.	NULL
Lin	NULL
,	NULL
A.	NULL
Mustafa	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Viral	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
interferon	NULL
promoter	NULL
:	NULL
modulation	NULL
of	NULL
transcription	NULL
by	NULL
NF-B/Rel	NULL
proteins	NULL
and	NULL
interferon	NULL
regulatory	NULL
factors	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:4707	NULL
.	NULL

Boothby	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
L.	NULL
Mora	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1997	NULL
.	NULL

Perturbation	NULL
of	NULL
the	NULL
T	NULL
lymphocyte	NULL
lineage	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-B.	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1897	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6450	NULL
35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

Esslinger	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
B.	NULL
Sordat	NULL
,	NULL
F.	NULL
Beermann	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1997	NULL
.	NULL

Abnormal	NULL
T	NULL
lymphocyte	NULL
development	NULL
induced	NULL
by	NULL
targeted	NULL
overexpression	NULL
of	NULL
IxBa	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5075	NULL
.	NULL

Allen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
K.	NULL
A.	NULL
Forbush	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Perlmutter	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
dissection	NULL
of	NULL
the	NULL
Ick	NULL
proximal	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:2758	NULL
.	NULL

Lewis	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
C.	NULL
C.	NULL
Yu	NULL
,	NULL
K.	NULL
A.	NULL
Forbush	NULL
,	NULL
J.	NULL
Carpenter	NULL
,	NULL
T.	NULL
A.	NULL
Sato	NULL
,	NULL
A.	NULL
Grossman	NULL
,	NULL
D.	NULL
H.	NULL
Liggitt	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Perlmutter	NULL
.	NULL

1989.	NULL
interleukin	NULL
4	NULL
expressed	NULL
in	NULL
situ	NULL
selectively	NULL
alters	NULL
thymocyte	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:89	NULL
.	NULL

Transgenesis	NULL
technics	NULL
,	NULL
principles	NULL
and	NULL
protocols	NULL
.	NULL

In	NULL
Methods	NULL
in	NULL
Molecular	NULL
Bi-ology	NULL
,	NULL
Vol	NULL
.	NULL

18	NULL
.	NULL

D.	NULL
Murphy	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Carter	NULL
,	NULL
eds	NULL
.	NULL

Humana	NULL
Press	NULL
,	NULL
Totowa	NULL
,	NULL
NJ	NULL
,	NULL
pp	NULL
.	NULL

109-182	NULL
.	NULL

Kruisberg	NULL
,	NULL
A.	NULL
M.	NULL
1992	NULL
.	NULL

Isolation	NULL
and	NULL
fractionation	NULL
of	NULL
mononuclear	NULL
cell	NULL
populations	NULL
.	NULL

In	NULL
Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Jaffray	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
Wood	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Hay	NULL
.	NULL

1995	NULL
.	NULL

Domain	NULL
organization	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
and	NULL
sites	NULL
of	NULL
interaction	NULL
with	NULL
NF-kB	NULL
p65	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2166	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Gouy	NULL
,	NULL
G.	NULL
Bismuth	NULL
,	NULL
L.	NULL
M.	NULL
Lee	NULL
,	NULL
P.	NULL
Debré	NULL
,	NULL
and	NULL
M.	NULL
Kérner	NULL
.	NULL

1991	NULL
.	NULL

NF-KB	NULL
activation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
is	NULL
independent	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
Ca**-regulated	NULL
kinase	NULL
.	NULL

Cytokine	NULL
3:257	NULL
.	NULL

Leo	NULL
,	NULL
O.	NULL
,	NULL
M.	NULL
Foo	NULL
,	NULL
D.	NULL
H.	NULL
Sachs	NULL
,	NULL
L.	NULL
E.	NULL
Samelson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
a	NULL
murine	NULL
T3	NULL
polypeptide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:123	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
;	NULL
156.	NULL
.	NULL

Coligan	NULL
J.	NULL
E.	NULL
,	NULL
A.	NULL
M.	NULL
Kruisberg	NULL
,	NULL
D.	NULL
H.	NULL
Margulies	NULL
,	NULL
E.	NULL
M.	NULL
Shevach	NULL
,	NULL
and	NULL
W.	NULL
Strober	NULL
.	NULL

1996	NULL
.	NULL

Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Huang	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
H.	NULL
Chen	NULL
,	NULL
S.	NULL
Z.	NULL
Ben-Sasson	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1997	NULL
.	NULL

IL-4	NULL
and	NULL
IL-13	NULL
production	NULL
in	NULL
differentiated	NULL
T	NULL
helper	NULL
type	NULL
2	NULL
cells	NULL
is	NULL
not	NULL
IL-4	NULL
dependent	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3731	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
I	NULL
«	NULL
B	NULL
@	NULL
/MAD3	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
ReVNF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043	NULL
.	NULL

Ito	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
A.	NULL
G.	NULL
Kazantzev	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1994	NULL
.	NULL

Three	NULL
NF-KB	NULL
sites	NULL
in	NULL
the	NULL
IxBa	NULL
promoter	NULL
are	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:3787	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
M.	NULL
J.	NULL
Lenardo	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1989	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
x	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244:466	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
M.	NULL
Geerts	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Aarden	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF-B-like	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:14179	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
G.	NULL
Horvath	NULL
,	NULL
J.	NULL
Subleski	NULL
,	NULL
J.	NULL
Bruder	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1995	NULL
.	NULL

Rel	NULL
A	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
within	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4260	NULL
.	NULL

Sica	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
Dorman	NULL
,	NULL
V.	NULL
Viggiano	NULL
,	NULL
M.	NULL
Cippitelli	NULL
,	NULL
P.	NULL
Gosh	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
.	NULL

1997	NULL
.	NULL

Interaction	NULL
of	NULL
NF-KB	NULL
and	NULL
NFAT	NULL
with	NULL
the	NULL
interferon-y	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:30412	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
C.	NULL
Doyle	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9769	NULL
.	NULL

Abbadic	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Kabrun	NULL
,	NULL
J.	NULL
F.	NULL
Bouali	NULL
,	NULL
J.	NULL
Smardova	NULL
,	NULL
D.	NULL
Stchelin	NULL
,	NULL
B.	NULL
Bandenbunder	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Enrictto	NULL
.	NULL

1993	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
c-Rel	NULL
expression	NULL
are	NULL
associated	NULL
with	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
developing	NULL
avian	NULL
embryo	NULL
and	NULL
in	NULL
bone	NULL
marrow	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
75:899	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
preventing	NULL
TNF-a-induced	NULL
cell	NULL
death	NULL
.	NULL

Science	NULL
274:782	NULL
.	NULL

55	NULL
56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

T	NULL
CELL	NULL
ACTIVATION	NULL
AND	NULL
DEVELOPMENT	NULL
IN	NULL
IxBa	NULL
TRANSGENIC	NULL
MICE	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
S.	NULL
J.	NULL
Martin	NULL
,	NULL
T.	NULL
Kafri	NULL
,	NULL
D.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
TNF-	NULL
@	NULL
-induced	NULL
apoptosis	NULL
by	NULL
NF-kB	NULL
.	NULL

Science	NULL
274:787	NULL
.	NULL

Piqueras	NULL
,	NULL
B.	NULL
,	NULL
B.	NULL
Autran	NULL
,	NULL
P.	NULL
Debré	NULL
,	NULL
and	NULL
G.	NULL
Gorochov	NULL
.	NULL

1996	NULL
.	NULL

Detection	NULL
of	NULL
apoptosis	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
by	NULL
direct	NULL
incorporation	NULL
of	NULL
fluorescein-dUTP	NULL
in	NULL
DNA	NULL
strand	NULL
breaks	NULL
.	NULL

BioTechniques	NULL
20:634	NULL
.	NULL

Attar	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
H.	NULL
MacDonald-Bravo	NULL
,	NULL
C.	NULL
Raventos-Suarez	NULL
,	NULL
S.	NULL
K.	NULL
Durham	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1998	NULL
.	NULL

Expression	NULL
of	NULL
constitutively	NULL
active	NULL
I	NULL
«	NULL
B	NULL
#	NULL
in	NULL
T	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
:	NULL
persistent	NULL
NF-B	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
immune	NULL
responses	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:477	NULL
.	NULL

Veis	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
C.M	NULL
.	NULL

Sorenson	NULL
,	NULL
J.	NULL
R.	NULL
Shutter	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1993	NULL
.	NULL

Bel-2-deficient	NULL
mice	NULL
demonstrate	NULL
fulminant	NULL
lymphoid	NULL
apoptosis	NULL
,	NULL
polycystic	NULL
kidneys	NULL
,	NULL
and	NULL
hypopigmented	NULL
hair	NULL
.	NULL

Cell	NULL
75:229	NULL
.	NULL

Ma	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
C.	NULL
Pena	NULL
,	NULL
B.	NULL
Chang	NULL
,	NULL
E.	NULL
Margosian	NULL
,	NULL
L.	NULL
Davidson	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

Bcl-x	NULL
regulates	NULL
the	NULL
survival	NULL
of	NULL
double-positive	NULL
thymocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:4763	NULL
.	NULL

Motoyama	NULL
,	NULL
N.	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
K.	NULL
A.	NULL
Roth	NULL
,	NULL
H.	NULL
Sawa	NULL
,	NULL
K.	NULL
I.	NULL
Nakayama	NULL
,	NULL
I.	NULL
Negishi	NULL
,	NULL
S.	NULL
Senju	NULL
,	NULL
Q.	NULL
Zhang	NULL
,	NULL
S.	NULL
Fujii	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1995	NULL
.	NULL

Massive	NULL
cell	NULL
death	NULL
of	NULL
immature	NULL
hematopoietic	NULL
cells	NULL
and	NULL
neurons	NULL
in	NULL
Bcl-x-deficient	NULL
mice	NULL
.	NULL

Science	NULL
267:1506	NULL
.	NULL

Van	NULL
Parijs	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Tbraghimov	NULL
,	NULL
and	NULL
A.	NULL
K.	NULL
Abbas	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
costimulation	NULL
and	NULL
Fas	NULL
in	NULL
T	NULL
cells	NULL
apoptosis	NULL
and	NULL
tolerance	NULL
.	NULL

Immunity	NULL
4:321	NULL
.	NULL

Tucek-Szabo	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
S.	NULL
Andjelic	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
K.	NULL
B.	NULL
Elkon	NULL
,	NULL
and	NULL
J.	NULL
Nikolic-Zugic	NULL
.	NULL

1996	NULL
.	NULL

Surface	NULL
T	NULL
cell	NULL
Fas	NULL
receptor/CD95	NULL
regulation	NULL
,	NULL
in	NULL
vivo	NULL
activation	NULL
,	NULL
and	NULL
apo-ptosis	NULL
:	NULL
activation-induced	NULL
death	NULL
can	NULL
occur	NULL
without	NULL
Fas	NULL
receptor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156	NULL
;	NULL
192	NULL
.	NULL

Sytwu	NULL
,	NULL
H-K.	NULL
,	NULL
R.	NULL
S.	NULL
Liblau	NULL
,	NULL
and	NULL
H.	NULL
O.	NULL
McDevitt	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
roles	NULL
of	NULL
Fas/APOL	NULL
(	NULL
CD95	NULL
)	NULL
and	NULL
TNF	NULL
in	NULL
antigen-induced	NULL
programmed	NULL
cell	NULL
receptor	NULL
transgenic	NULL
mice	NULL
.	NULL

Immunity	NULL
5:17.	NULL
.	NULL

Terada	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
J.	NULL
Lucas	NULL
,	NULL
A.	NULL
Szepesi	NULL
,	NULL
R.	NULL
A.	NULL
Franklin	NULL
,	NULL
J.	NULL
Domenico	NULL
,	NULL
and	NULL
E.	NULL
W.	NULL
Gelfand	NULL
.	NULL

1993	NULL
.	NULL

Rapamycin	NULL
blocks	NULL
cell	NULL
cycle	NULL
progression	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
prior	NULL
to	NULL
events	NULL
characteristic	NULL
of	NULL
the	NULL
middle	NULL
to	NULL
late	NULL
G1	NULL
phase	NULL
of	NULL
the	NULL
cycle	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

154:7	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
L.	NULL
K.	NULL
Felzien	NULL
,	NULL
J.	NULL
C.	NULL
Betts	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
D.	NULL
H.	NULL
Beach	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
cyclin-dependent	NULL
kinases	NULL
associated	NULL
with	NULL
the	NULL
p300	NULL
coactivator	NULL
.	NULL

Science	NULL
275:523	NULL
.	NULL

Zhong	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
E.	NULL
Voll	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1998	NULL
.	NULL

Phosphorylation	NULL
of	NULL
NF-kB	NULL
p65	NULL
by	NULL
PKA	NULL
stimulates	NULL
transcriptional	NULL
activity	NULL
by	NULL
promoting	NULL
a	NULL
novel	NULL
bivalent	NULL
interaction	NULL
with	NULL
the	NULL
coactivator	NULL
CBP/p300	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
1:661	NULL
.	NULL

Bash	NULL
,	NULL
J.	NULL
,	NULL
W.	NULL
X.	NULL
Zong	NULL
,	NULL
and	NULL
C.	NULL
Gelinas	NULL
.	NULL

1997	NULL
.	NULL

C-Rel	NULL
arrests	NULL
the	NULL
proliferation	NULL
of	NULL
HeLa	NULL
cells	NULL
and	NULL
affects	NULL
critical	NULL
regulators	NULL
of	NULL
the	NULL
G1/S-phase	NULL
transition	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6526	NULL
.	NULL

Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1995	NULL
.	NULL

Cytokine	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
in	NULL
cycling	NULL
and	NULL
growth-arrested	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:18836	NULL
.	NULL

Casolaro	NULL
,	NULL
V.	NULL
,	NULL
N.	NULL
S.	NULL
Georas	NULL
,	NULL
Z	NULL
.	NULL

Song	NULL
,	NULL
I.	NULL
D.	NULL
Zubkoff	NULL
,	NULL
S.	NULL
A.	NULL
Abdulkadir	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Ono	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-AT-dependent	NULL
transcription	NULL
by	NULL
NF-KB	NULL
:	NULL
implications	NULL
differential	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
.	NULL

Immunology	NULL
92:11623	NULL
.	NULL

Ishikawa	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
E.	NULL
Claudio	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1997	NULL
.	NULL

Gastric	NULL
hyperplasia	NULL
and	NULL
increased	NULL
proliferative	NULL
responses	NULL
of	NULL
lymphocytes	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
COOH-terminal	NULL
ankyrin	NULL
domain	NULL
of	NULL
NF-kB2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:999	NULL
.	NULL

Eskdale	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Kube	NULL
,	NULL
H.	NULL
Tesch	NULL
,	NULL
and	NULL
G.	NULL
Gallagher	NULL
.	NULL

1997	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
human	NULL
IL10	NULL
gene	NULL
and	NULL
further	NULL
characterization	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
.	NULL

Immunoge-netics	NULL
46:120	NULL
.	NULL

Goldfeld	NULL
A.	NULL
E.	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
C.	NULL
Doyle	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:73	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

